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ABSTRACT
A SYSTEMS BIOLOGY APPROACH IDENTIFIES A GENE REGULATORY
NETWORK IN PAROTID ACINAR CELL DIFFERENTIATION
By
Melissa Ann Metzler
January 25, 2016

Objective: This project sought to understand the gene regulatory networks that
drive parotid salivary gland acinar cells to terminally differentiate, and drive
expression of terminal differentiation genes in dedifferentiated ParC5 cells.
Methodology: Laser capture microdissection was used to isolate acinar cells at
multiple time points during differentiation. This important step allowed us to
measure gene expression in a single and important cell type. A systems biology
approach was taken to measure global mRNA and microRNA expression across
acinar cell terminal differentiation in the rat parotid salivary gland. In ParC5 cells,
the ER stress activator tunicamycin was used to stimulate Xbp1 activity. Results:
Profiles of statistically significant changes of mRNA expression, combined with
reciprocal correlations of microRNAs and their target mRNAs, suggest a putative
network involving Xbp1 and Mist1 (BHLHA15). The network suggests that a
molecular switch involving Prdm1, Sox11, and Pax5 progressively decreases
repression of Xbp1 transcription, in concert with decreased translational
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repression by miR-214. Transfection studies validate each of the tested network
interactions. Treatment of ParC5 cells with tunicamycin increases expression of
Mist1 downstream of Xbp1. However, further downstream effectors of Xbp1 and
Mist1 (i.e. PSP, Connexin32) remain unchanged. The Mist1 target gene Rab3D
is repressed. However, transfection of Mist1 cDNA, increases Rab3d expression.
Conclusion: This study identified numerous novel transcription factor
expressionpatterns during parotid acinar differentiation, including Pparg, Klf4,
and Sox11. Many differentially expressed microRNAs were also measured which
have not previously been described in salivary development. Network analysis
identified a gene regulatory network driving expression of terminal differentiation
genes. Stimulating Xbp1 activity in ParC5 cells increases Mist1 expression as
predicted in the network, but other factors or epigenetic changes may be required
for full expression of the network.
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CHAPTER 1: INTRODUCTION
The major salivary glands are exocrine organs that are vital for maintaining oral
health. Saliva components provide numerous protective functions in the oral
cavity that are unmatched by any other artificial fluid. Millions suffer from gland
dysfunction and destruction, and as a result have chronic hyposalivation. These
patients generally have poor oral health and reduced quality of life. Regenerating
or growing artificial glands for these patients requires increased understanding of
how exocrine cells differentiate. This work takes a systems biology approach by
measuring both mRNA and microRNA expression changes across acinar cell
differentiation and integrating them into a model of gene regulatory interactions
that drive differentiation.
1.1 Salivary Gland Anatomy, Cell Types, and Function
1.1.1 Introduction and Basic Anatomy
In mammals, as well as in many terrestrial animals, the salivary glands are a
constitutive source of moisture, salt, and proteins which coat the oral cavity and
are vital for maintaining oral homeostasis [1-3]. Saliva contributes to many
functions in the oral cavity, and as described in a later section, its loss is
devastating to oral health and quality of life
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There are two main types of glands in mammals: major and minor. Named for
their relative size, the major glands are much larger than the minor glands, and
are the focus of this study. There are three major paired glands, and they secrete
~ 90% of total saliva. They are the submandibular (SMG), the sublingual (SLG),
and the parotid gland (PG). Their locations in humans can be seen in the
diagram in Figure 1.1. Both the SMG and the SLG are located under the tongue,
while the PG is found in front of and below the ear, flanking the jaw hinge [1].
Gland epithelia can be described as secretory units that exist as clusters of
exocrine cells (acini) which are connected by a highly branched duct system and
drain into the oral cavity [4]. The three major glands differ slightly in morphology
(the SMG is densely packed whereas the branches of the PG are more spaced
out) [5, 6]. They also differ with respect to type of secretion, due to different types
of acinar cells. The SMG contains mucosal acini which secrete a viscous saliva
high in mucin content, while the PG have purely serous acini which do not
contain mucins and produce more watery saliva [1, 7] that nonetheless contains
a large number of proteins including amylase and the parotid secretory protein
(PSP). The parotid is considered responsible for most stimulated flow [8] [9].
The SMG and PG are connected to the oral cavity through their own designated
ducts. Each of the paired SMG drains into a single duct know as Wharton's duct
under the tongue, and the PG empties into the Stensen duct found opposite the
upper second molar in humans [1]. The SLG, on the other hand, may have more
than a dozen ducts on the floor of the mouth. The glands are enclosed in
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Parotid Gland

Tongue

Masseter muscle

Sublingual Gland

Submandibular Gland

Figure 1.1 Salivary Gland Anatomy. The locations of the three major salivary
glands is shown in humans. Both the submandibular and the sublingual glands
are found underneath the tongue and are connected to the oral cavity through
ducts found on the floor of the mouth. The parotid glands are the largest in
humans. They are located on each side of the face in front of the ear, extending
down to the lower jaw, and overlapping the masseter muscle. The parotid duct
connects to the oral cavity in the back of the mouth, near the upper second
molar.
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mesenchyme capsules, and are innervated by both parasympathetic and
sympathetic fibers which control secretion [1, 2, 10].
Nerves, particularly parasympathetic nerves, are required for secretion. They
control both a "resting" or basal flow rate which occurs at all times, and a short
term stimulated flow rate where the flow of saliva can be increased 10-fold or
more. Also, many types of receptors can indirectly stimulate this increased flow,
including mechanoreceptors, olfactory receptors, and gustatory receptors [11].
Evidence suggests that not only can these stimuli alter the flow of saliva but its
components as well. For instance saliva collected from the oral cavity after
stimulation with sugar has been found to contain more protein than saliva
stimulated with citric acid [12]. This level of control makes saliva ideal for
maintaining homeostasis of an oral cavity which may undergo many different
types of assaults on a daily basis.
1.1.2 Cell Types
The acinar cells produce and secrete most of saliva's components. They are
highly specialized terminally differentiated cells, which are vital for fully
functioning glands. They are pyramid-shaped cells packed into clusters around a
well-defined lumen at the end-points of the ductal branches. The apical
cytoplasm is generally filled with electron dense secretory vesicles, and they
have a well-developed Golgi complex and rough endoplasmic reticulum [13-15].
There are two types of acinar cells which can be identified by the types of
proteins found in the vesicles: mucosal acinar cells contain large amounts of
mucin proteins, and serous acinar cells contain densely packed proteins,
4

including many enzymes, but no mucins, and these vesicles generally appear
darker.
In humans, the parotid gland contains purely serous acini, and the
submandibular is purely mucosal. The sublingual gland contains a mixture of
mucosal and serous cells within a single acinus with mucosal acinar cells forming
a cluster which are capped by serous demilune cells [16].
The acini are surrounded by myoepithelial cells which are innervated and are
thought to aid secretion through contraction [1, 13].
The ductal cells modify saliva as it passes from the acini, mostly by reabsorbing
salt [13]. Saliva is hypotonic to plasma, and this is thought to contribute to taste
[10].
1.1.3 Exocrine Secretion
Secretion from parotid acinar cells is fairly complex and has been found to
involve several different pathways [17], which can be classified into two main
types: regulated secretion, which involves stimulation from the nervous system,
and constitutive secretion which does not.
The regulated secretion pathways involve beta-adrenergic stimulation leading to
accumulation of intracellular cAMP, and elevation of intracellular Ca2+ by
muscarinic stimulation, ultimately leading to the release of protein cargo from
secretory granules. This type of pathway accounts for 80 – 90% of protein
secretion from the parotid [17]. These pathways involve the large secretory
granules which are directed towards the apical membrane and densely packed
5

with protein cargo (i.e. amylase, PSP, RNaseI). The membrane of these mature
granules also contain proteins including the SNARE VAMP-2, and two GTPbinding proteins Rab3d and Rab26. VAMP-2 is essential for fusion with the
plasma membrane, and the Rab proteins have been found to be vital for granule
maturation and recruitment to the plasma membrane [18-20].
1.1.4 Saliva Components and Oral Health
Although saliva has been found to be ~90% water, it contains many protein and
salt components which benefit the oral cavity, and make it a difficult fluid to
replicate artificially.
Several studies have been done to identify the complete proteome of saliva [21,
22]. The most comprehensive analysis of the whole salivary proteome to date
has identified over 1000 different proteins, most coming from the major salivary
glands. Individual secretions from the submandibular and parotid gland have also
been analyzed. Each gland contributes close to 1000 proteins, with about a 60%
overlap between them [23]. These proteins contribute to many functions in the
oral cavity ranging from digestion, antimicrobial protection, lubrication, taste, and
speech.
One of the main proteins in saliva are mucins which are supplied mostly by the
SMG. In humans mucins are expressed from two genes: MUC5B and MUC7,
and each gene may have many glycoforms. MUC5B is the more heavily
glycosylated (> 80%) and is the main contributor to the viscosity of saliva, which
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has a gel-like consistency that coats and forms a barrier on epithelial and enamel
surfaces. It also protects against acids.
MUC7 is smaller and does not appear to increase viscosity. It is, unlike MUC5B,
specific to salivary glands. MUC5B coats many other surfaces such as in the
intestines. MUC7 has been found to bind to several species of bacteria that are
found in the oral cavity, and along with agglutinin (an anti-bacterial protein
secreted from all three major glands), contributes to the aggregation and
clearance of bacteria.
Other types of antimicrobial proteins include enzymes. The most prevalent and
probably the most well-known enzyme in human saliva is amylase. This enzyme
is produced largely by the parotid gland, and catalyzes the alpha amylase
reaction, the first reaction in starch digestion to produce glucose. Aside from
aiding in digestion, breaking down starch in the oral cavity allows the taste of
sweetness to be perceived [24].
In humans there are five amylase isozymes found in a gene cluster on
chromosome 1 [25]. Three of the genes are salivary specific and the remaining
two are produced in the pancreas. Interestingly, the salivary amylase genes have
variable copy numbers in the human population (from 2-15 copies based on a
survey of 50 individuals) [26]. A recent study also found a correlation between
amylase copy number and diet, with more copy numbers in populations with a
grain heavy diet and less in populations that relay on a low starch diet [26].
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A survey of amylase expression throughout the mammalian kingdom further
suggests that salivary amylase evolves alongside diet. Pure carnivores, such as
cats and dogs, do not produce amylase in their saliva, and ruminants such as
sheep have very little amylase [24]. While the exact physiological significant of
amylase activity in the oral cavity is still being investigated, the evolution of
salivary specific amylase expression suggests it is important in animals with a
starch heavy diet.
Saliva has also been reported to contain chitinase activity most likely due to
secretions from the parotid [27]. Chitin is a major component of the yeast cell wall
and this protein could act as an anti-fungal. Lysozyme is another enzyme found
in saliva which acts as an anti-fungal and is thought to contribute to controlling
candida growth in the mouth. It has been suggested that the salivary glands,
particularly the parotid, can respond to higher candida loads by secreting more
lysozyme [28].
There are also many types of antimicrobial proteins in saliva such as the PLUNC
(palate, lung, and nasal epithelium clone) family Parotid Secretory Protein (PSP,
aka BPIFA2), which is related to the BPI (bactericidal/ permeability-increasing)
protein. PSP has been found to have anti-inflammatory as well as antibacterial
activity. This protein contains hydrophobic regions, and has been shown to bind
to LPS, likely though regions with similarity to Lipopolysaccharide-Binding Protein
(LBP) [29]. Several peptides of this protein have been shown to inhibit LSP
stimulated secretion of TNFα from macrophages. In a mouse model of sepsis,
co-injection of a PSP peptide with P. aeruginosa LPS increased survival
8

compared to the LPS alone. This protein also acts as an agglutinin. Incubation of
PSP with P. aeruginosa led to the aggregation of the bacteria which has been
shown to aid in clearance by inhibiting attachment.
These are just a few examples of known functions for saliva components.
Knowledge continues to grow and it is likely that proteins will have more than one
function. It is clear that saliva has been adapted for our survival and for our diet;
its loss would be devastating for our oral health.
1.2 Gland Dysfunction and Oral Health
1.2.1 Xerostomia and Oral Health
Xerostomia (dry mouth) is a common complaint among the general population,
with some surveys finding perceived xerostomia in more than 25% of
respondents [30, 31]. Generally, it is reported more often by women and the
elderly. Although the presence of xerostomia can be considered subjective, it is
often accompanied by hyposalivation which is determined more objectively by a
decrease in salivary flow. This is defined by a resting flow rate less than 0.1
ml/min or a stimulated rate less than 0.7 ml/min [32]. The absence or reduction of
saliva leads to a dramatic increase in oral health problem such as caries (tooth
decay caused by bacteria, commonly called cavities), ulcerations, periodontitis,
and opportunistic infections such as candida [31, 33]. Patients also experience
discomfort, difficulty chewing, swallowing, and even speaking. This can have a
drastic impact on quality of life.
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There are many causes of hyposalivation, but they generally fall into three major
categories: medication, autoimmune disorder, and radiation therapy.
Many medications list xerostomia as a side effect. Drugs with anticholinergic
activity are the most reported, but there are many other classes which are
thought to reduce salivary function such as antihistamines, decongestants,
tricyclic antidepressants, and others, though in most cases the mechanism is not
known [33]. This mostly affects the elderly population which generally report
taking more medications. Salivary dysfunction is rarely irreversible in these
cases, and salivary flow usually returns to normal when patients stop taking the
drug.
Autoimmune disorders are cause by the immune system attacking host tissue,
leading to damage. Disorders involving the exocrine glands affects tens of
millions of individuals. The most common of these is Sjogren's syndrome (SS)
which varies in prevalence from 0.1% to 4.8% of the population. This variation is
thought to be due to ethnic and geographical differences. Onset is most common
in women in their 40's and 50's, and is the second most common autoimmune
disorder behind rheumatoid arthritis. It is usually considered a chronic and
progressive disease. A characteristic of SS is immune cell infiltration, particularly
of the salivary glands. Overtime the acinar cells atrophy and are replaced with
fibrotic and fatty tissue, however, several studies have determined that function is
greatly reduced long before cells are lost possibly due to production of nitric
oxide (NO) or autoantibodies that target muscarinic receptors [34-36].
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Radiation therapy is also responsible for xerostomia in thousands of patients.
Every year there are 30,000 – 40,000 new cases of head and neck cancer, and
chronic xerostomia is considered the most common complication of treatment.
Radiation treatment is part of the standard of care, and is sometimes combined
with surgery and chemotherapy. Because of current limitations, the radiation field
usually includes some healthy tissue which usually involves the salivary glands.
For reasons not completely known, the salivary glands are especially sensitive to
radiation [37]. Unlike many radiosensitive cells, they are not highly proliferative.
The most recent hypothesis involves acute disruption in the plasma membrane
which interferes with muscarinic receptor stimulation without killing the cells (this
satisfies the observation that patients experience hyposalivation quickly after
therapy begins (~ 1 week), but there is no observed loss of cells). Later damage,
and loss of cells, particularly acinar cells is observed (damage can continue to
progress for several months after treatment), and this is thought to be due to
more "classical" radiation damage, that is, DNA damage of progenitor cells
causes lethality when these cells try to re-enter the reproductive cycle and
replenish gland tissue. These patients rarely recover gland tissue, and end up
suffering from permanent chronic hyposalivation [38-40].
1.2.2 Treatment of Hyposalivation
Most treatments available to patients with xerostomia involve managing
symptoms, and preventing oral health problems. Currently, there is no way to
regenerate or regrow functioning tissue, and patients generally face a lifetime of
managing this disorder.
11

Commonly patients will consume more water in order the combat the feeling of
dry mouth. However, xerostomia is usually not caused by dehydration and thus
this is not expected to confer any long-term benefit though it may help with some
symptoms such as discomfort, and may aid in chewing and swallowing [31].
There are also an array of saliva substitutes on the market featuring many
different formulations. The base for these solutions covers a wide range of
options including glycerol, animal mucins, and several types of methylcellulose.
Some products contain fluoride, others lemon juice (to stimulate residual gland
activity, citric acid is the most effective natural stimulator of salivation), though
long-term use of an acid can lead to enamel erosion [31, 41]. Despite the long list
of options available, few studies have compared their benefit, and there is
currently no accepted gold standard saliva substitute. It is important to note that
no artificial substitute contains all of the wide array of components of natural
saliva, and so is not likely to confer all the same protective benefits. Also these
solutions must be applied every few hours as they are easily washed away [42].
The American Dental Association (ADA) recommends that dentist encourage
patients to make changes in their daily life to avoid exacerbating oral
complications. These include tobacco cessation, alcohol-free mouth wash, and a
reduction in dietary sugar [42]. Patients will also expect to visit a dentist more
frequently (every 3-6 months). However, a 2007 review noted that pre-treatment
dental consultations for patients with head and neck cancer was low, and
compliance with oral care recommendations was poor [43].
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There are currently two FDA approved medications used to stimulate saliva flow
and alleviate hyposalivation: these are pilocarpine and cevimeline hydrochloride,
referred to as "sialogogues." They are cholinergic agonists, and are used to
stimulate any remaining gland tissue. These medications must be taken 3 to 4
times a day and side effects include sweating, nausea, and rhinitis. Patients vary
in their response to these drugs, usually depending on how much healthy tissue
remains. Those with extensive damage and loss of cells may receive no benefit
at all [42].
In radiation therapy, several interventions have been developed to protect the
salivary glands from damage in the first place. The use of intensity-modulated
radiation therapy (IMRT) has been shown to spare the salivary glands by
reducing their exposure to radiation, and has been shown to reduce the
incidence of xerostomia in these patients [44]. For instance, follow up of phase
I/II patients showed that patients receiving IMRT recovered 63% of their flow rate
one year after treatment, compared to 3% in the patients that received
conventional radiation (these glands received a cumulative dose of 19.9Gy or
57.5Gy respectively, and a baseline of 26Gy is now widely considered a
threshold for salivary gland sparing) [45, 46]. Another method to prevent damage
is to move one of the submandibular glands out of the field of radiation in a
procedure termed salivary gland transfer (SGT). It was developed in 2000 and
has been used on hundreds of patients in the last decade [47]. Recent metaanalysis has supported the claim that this treatment is effective in preventing
xerostomia [48, 49].
13

Although these preventative techniques may help many of the hundreds of
thousands diagnosed with head and neck cancer every year, these measures will
not help all patients, and there are still millions already suffering from gland
hypofunction with little effective treatment options available. Therefore,
considerable emphasis has been placed on developing therapeutic approaches
based on controlling differentiation or regeneration of damaged salivary glands.
1.3 Regenerating Salivary Glands
1.3.1 Stem Cells
Several recent studies have focused on identifying stem cells capable of
differentiating into gland cells, particularly acinar cells. In the case of head and
neck cancer patients, for instance, the stem cells could be isolated from patients
before radiation treatment, and then transplanted back after radiation treatment.
It has long been thought that the salivary glands themselves contain stem cells
residing within the ducts, and are mainly responsible for maintaining gland tissue
[50, 51]. These ductal progenitors are also thought to be the source of gland
regeneration following ductal ligation, when most acinar cells atrophy [52, 53].
However, recent work has suggested that clonal expansion of acinar cells
maintains tissue homeostasis, with little contribution from the ducts [54].
However, this does not exclude the possibility that there is a stem cell population
in the glands. Many groups have identified different prospective stem cells in the
gland, and have exploited their pluripotent potential to grow both ductal and
acinar cells in vitro and in vivo.
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Nanduri et. al. [55] was able to show immune-histochemical staining of several
stem cell markers in the ductal compartment of mouse submandibular glands
including c-Kit, CD133, CD24, CD29, and CD49f. Interestingly, culturing gland
cells as salispheres, enriches a c-Kit+ population after several days [56]. As
reported by Lombaert et. al. [57] initial spheres contained both ductal and acinar
cells, as well as c-Kit- and c-Kit+ cells. After 2 or 3 days in culture, the acinar
cells disappeared and most of the remaining cells were c-Kit+. Over the next
several days, acinar cells began to reappear, as indicated by PAS+ staining and
IHC for amylase, suggesting these cultures contained stem cells capable of
differentiation into acinar cells.
In a rescue experiment, cells from three day cultured spheres were injected into
the glands of irradiated mice. The donor was a male expressing a GFP reporter,
and the recipients were wild type female mice 30 days after receiving local
radiation which destroyed their salivary glands. Glands and salivary flow were
examined 90 days after transplantation. Mice that received the transplantation
had significantly more salivary flow and increased acinar surface area compared
to irradiated, non-transplanted animals. There were many GFP positive cells at
the injection site, all ductal cells, and subsequent in situ hybridizations confirmed
the presence of donor derived acinar cells based on hybridization with the Y
chromosome. This indicates that these cells are differentiating and incorporating
into the gland rather than relying solely on some paracrine affect to stimulate
growth of existing cells.
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c-Kit+ cells have also been identified in human submandibular and parotid
glands. Salisphere cultures seem to behave in much the same way as the
mouse, and c-Kit+ cells could be isolated from 3 day cultures [57].
Bone marrow stem cells have also been investigated for the ability to rescue
gland function post-irradiation. As in the salivary gland stem cell experiments,
bone marrow stem cells were isolated from a donor mouse (specifically bone
marrow mesenchymal stem cells), and transplanted into the glands of an
irradiated mouse. Mice that received the stem cells showed a significant increase
in saliva production, compared to PBS controls, as well as a preservation of
morphological features, including acinar cells. Donor cells were identified in the
recipient gland by use of a tracking dye, and in a few cells fluorescence from the
dye co-localized with amylase staining indicating transdifferentiation [58].
The use of stem cell based therapies appears promising as it could potentially
regrow tissue for patients from their own cells. Several candidate cell populations
have been proposed and tested in mice, and one population, c-Kit+ cells, have
been isolated in humans. These cells have the ability to differentiate into both
ductal and acinar cells both in vitro and in vivo. However, many patients no
longer have progenitor or stem cells remaining, and so alternative therapies
continue to be developed. Importantly, there is little understanding of the
regulatory pathways which control differentiation into acinar cells.
1.3.2 Bioengineered Glands
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While the transplantation of individual stem cells has shown promise, there is
also research into constructing three-dimensional structures in culture for grafting
into patients. One method, termed the organ germ method seeks to recapitulate
the process of development and differentiation in culture starting with isolated
epithelial and mesenchymal cells from an embryo, and resulting in a gland germ
in culture that can be transplanted [59]. This method has been successful in
growing all three of the major salivary glands in mice. Transplantation of the
submandibular gland germ in mice was also successful. The gland continued to
grow and develop in vivo, it expressed terminal differentiation markers such and
Aqp5, and amylase, and responded to proper nerve stimulation [60]. While the
engineering of a working organ from gland germ cells in culture is impressive, the
reliance on embryonic germ cells means this technique could probably not be
developed for use on patients in the clinic. Other types of cells and threedimensional culturing techniques have been investigated for their use in growing
differentiated cells in vitro, with the ultimate goal of building an implantable
artificial salivary gland. This could aid patients with extensive gland damage that
no longer possess progenitor cells. By using donor cells and an appropriate
scaffold, a working gland could be constructed for them.
The challenges of constructing an artificial gland largely stem from the fact that it
is difficult to grow differentiated salivary cells (particularly acinar cells) in vitro.
Primary cells are generally short lived, and are also known to transdifferentiate in
culture [61]. There are several salivary gland cell lines, but none of them harbor
all the characteristics of fully differentiated cells. It would be very useful to
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develop an understanding of the regulatory pathways to drive and maintain
differentiation in culture.
Current work in this area has focused on the role of the culturing scaffold. In
creating a three dimensional environment that more closely resembles the in vivo
structure (rather than culturing cells in a 2D monolayer), several groups have
been able to recreate some characteristics of fully differentiated cells. Several
cell lines grown on matrigel, for instance, have become more differentiated. HSG
cells are a neoplastic cell line derived from human intercalated duct cells from a
submandibular gland. When grown on plastic these cells form a flat monolayer,
do not express any tight junction (TJ) proteins, which are needed for apical/basal
polarity and proper secretion, and do not express Aquaporin5 (AQP5) which is
needed for fluid secretion. Culturing on matrigel leads to the formation of three
dimensional spheres that express many TJs that are also properly localized to
the apicolateral membrane. These cells also express AQP5, they contain
electron dense granules, and increased expression of amylase [62]. Similarly,
ParC10 cells (a cell line derived from primary rat parotid acinar cells, and
immortalized with simian virus 40 (SV40)[63, 64] also organize into lumenized
spheres on matrigel, express apically localized TJ proteins, basally localized
muscarinic receptor, and increased expression of AQP5 [65].
Unfortunately, matrigel cannot be used for in vivo applications as it is derived
from a mouse sarcoma cell line [66] and several studies have found it to be
tumorigenic [67-69]. Culturing cells on fibrin hydrogels has been investigated, but
it has failed to produce the same three dimensional morphology [67]. As an
18

alternative technique, one group has developed precisely constructed craters
lined with poly-lactic-co-glycolic acid (PLGA) nanofibers to mimic a basement
membrane. Increasing the curvature of the crater was found to increase cell
polarity and expression of AQP5 [70, 71].
These new techniques indicate a limited amount of control over the differentiation
process of acinar cells, and we are still a long way from recreating fully
differentiated cells in culture. This will take an increased understanding of
differentiation in vivo in order to identify important factors and networks that drive
differentiation, which could then potentially be applied in culture.
1.4 Gland Development and Cell Differentiation
1.4.1 Gland Development and Contribution from Outside Signaling
All three major glands develop by branching morphogenesis, although at
different times. The submandibular gland is the first to develop, followed by the
sublingual, and finally the parotid. In the rat, parotid development begins around
embryonic day 16.5 and continues until postnatal day 25. Development can be
characterized by five major events: formation of a prebud thickening in the oral
epithelium, an initial bud that protrudes into the surrounding mesenchyme,
branching morphogenesis, canalization of the ducts and end buds to form a
continuous lumen, and cellular differentiation [1, 13]. Along with the epithelium
and mesenchyme, endothelial and neuronal cells also grow alongside the gland.
Signaling between these cells types has been found to control many events in
development.
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It has long been known that the mesenchyme is important for branching
morphogenesis. Ex vivo studies involving the salivary glands date back to the
1950's when Grobstein et. al. [72] was able to show that branching
morphogenesis does not occur when salivary epithelium is mixed with the
mesenchyme from a different source. During his experiments, he physically
separated the epithelium from the mesenchyme using a filter and concluded that
proper branching was due to "diffusible factors" between the two tissues.
Later studies in knockout mice showed that Fgfr2b (fibroblast growth factor
receptor 2b) null and Fgf10 (fibroblast growth factor 10) null mice do not have
salivary glands. In these animals an initial bud forms, but does not undergo
branching morphogenesis [73]. Hoffman et. al. [74] profiled the expression of
many FGFs and FGFRs in the mouse submandibular gland during branching
morphogenesis. They measured expression in the epithelium and mesenchyme
separately, and found that Fgfr2b is expressed in the epithelium while Fgf10 and
Fgf7 are expressed in the mesenchyme. In functional studies of FGFR signaling,
ex vivo glands were incubated with soluble recombinant FGFRs in order to
competitively bind ligands. Of all the recombinant proteins used, rFGFR2b had
the largest effect on reducing branching morphogenesis. In a rescue experiment,
adding exogenous Fgf10 or Fgf7 could restore proper branching [75]. This FGF
secretion from the mesenchyme is thought to be stimulating localized cell
proliferation at the end buds.
Signaling from the parasympathetic ganglion (PSG) has also been shown to be
vital for several functions during organogenesis. The PSG condenses around the
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gland soon after the initial bud is formed. It branches and grows alongside the
gland, and is also known to be essential for gland regeneration. In ex vivo
studies, removal of the PSG around the time of branching morphogenesis stunts
growth and reduces the number of branches. Removal does not affect the
expression of genes involved in FGF signaling, indicating that the PSG
contributes to growth via a completely separate mechanism from the
mesenchyme. The PSG was found to contribute to growth via maintaining an
adequate progenitor cell population through EGFR (epidermal growth factor
receptor) signaling [76]. The PSG has also been found to control ductal cell
polarization and lumen formation through secreting vasoactive intestinal protein
(VIP) [77].
1.4.2 Acinar Cell Differentiation
Acinar cell terminal differentiation largely occurs during postnatal development.
From observational studies in the rat parotid, terminal clusters in the late embryo
do not appear to have a lumen, cells contain only a few sporadically located
electron dense granules, and the endoplasmic reticulum and Golgi are relatively
small. Within the first 24 hours of birth, amylase expression increases along with
the number of secretory granules, and a lumen begins to form. Over the next few
weeks the exocrine cells become polarized with apically located secretory
granules (which progressively increases in size and number), and basally
localized nucleus. There is an expansion of the rough ER and Golgi. The
expression of cargo proteins such as amylase and RNaseI progressively
increases, while the protein DNase I is not detected until the second postnatal
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week. The cells are considered fully differentiated around postnatal day 25 (P25)
[78, 79].
Unlike the case of branching morphogenesis where many signaling pathways
have been identified, not much is known about what drives terminal
differentiation. Several studies points to the fact that differentiation is at least
partially independent from morphogenesis, and most likely involves a separate
set of pathways [6]. For instance, the heterotypic recombination of epithelial cells
and mesenchyme that altered gland morphogenesis does not appear to change
the cytodifferentiation of the terminal bud cells. Lawson et. al. [80] found that
when a parotid rudiment is cultured with submandibular mesenchyme the gland
structurally resembles the SMG which is denser and tightly packed. However, the
acinar cells still develop amylase expression, which is a property of parotid
epithelium, not SMG. The reverse observations can be seen when SMG
epithelium is cultured with parotid mesenchyme [80]. In another study using the
SMG, embryonic epithelia (16 days) was separated from the mesenchyme and
grown in culture. Despite the fact that morphogenesis had been disrupted, the
cells were able to differentiate and form into distinct ductal and acinar cell
lineages. The authors do point out that if the mesenchyme was separated before
branching occurred, then cytodifferentiation does not take place, indicating these
two process are coupled very early in development but eventually become
independent [81]. This also points to the fact that cytodifferentiation may be less
dependent on signaling molecules from other tissues, and is instead intrinsic to
the epithelial cells themselves, especially in the later stages of development.
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Understanding the regulatory networks inside these cells that drives this process
will aid in our understanding of differentiation, and is the primary goal of this
dissertation.
1.5 Systems Biology and Salivary Gland Development
Organogenesis is a complex process involving many different pathways which
are spatially and temporally regulated. These pathways affect many different
cellular functions such as proliferation, migration, apoptosis, and lineage specific
gene expression to drive the overall patterning of the organ and the
differentiation of individual cell types. Many of these pathways are interconnected
or occurring in parallel. The goal of systems biology is to build as inclusive a
model as possible of all the factors that drive a particular function. These models
can then be used as hypothesis driving tools to further test and understand the
system.
Cleft formation is an important part of branching morphogenesis, which occurs
alongside proliferation and migration to form the overall shape of the organ, and
recently systems level modeling has been used to identify controlling factors.
Indentations, known as clefts, form spontaneously at the leading edge of the end
buds. Once an initial cleft is stabilized it will deepen, and eventually drive the end
bud apart into two branches. This occurs many times as the epithelium grows
and is important for forming a multibranched structure. This process is thought to
involve many functions including cytoskeleton arrangement, cell-cell attachment,
and cell-matrix attachment [82]. Recently a mathematical model has been
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developed to understand the contribution of these functions to the clefting
process [60].
An important part of systems level analysis is expression profiling, where the
expression of many molecules are measured under the condition of interest,
which can then be used as a starting point to build a model. Several expression
profiling experiments in the salivary gland have already increased our knowledge
of development. In Ectodysplasin A null Eda -/- mice, for instance, salivary
development is delayed, and the profiling of gene expression over the course of
branching morphogenesis in the knockout versus wild type indicated a novel
signaling pathway, possibly involving C/EPBα, which was counter to ex vivo
observations in which Eda was predicted to work by activating the NFκB pathway
[83]. This also highlights the importance of measuring changes within the organ
in vivo rather than under artificial conditions. There has also been an effort to
catalogue ex vivo gene expression at several micro anatomic regions of interest
in the branching epithelium (i.e. main duct, secondary duct, basement of cleft,
end bud), and these expression data have been made available to the field as a
searchable gene expression atlas [84]. Using laser capture, these specific
regions could be isolated and RNA expression compared between them in order
to identify molecules involved in different spatially regulated processes. By
comparing expression at the base of the cleft versus the end bud periphery, for
instance, the authors identified hundreds of differentially expressed genes,
including GSK3β which was expressed much lower in the clefts. This protein is
involved in E-cadherin stability. Pharmacological inhibition of GSK3β lead to an
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increase in cleft formation which did not progress to secondary ducts [85]. This
example highlights how systems level analysis can be used to identify novel
interacting molecules and form new hypothesis which can then be interrogated
with more traditional approaches.
While many studies have focused on morphogenesis, relatively little attention has
been paid to cellular differentiation. Differentiation can be thought of as enduring
changes in gene expression which are vital for the unique function of each
individual cell type. For instance, salivary acinar cells acquire the expression of a
multitude of cargo proteins as well as the cellular machinery necessary for the
trafficking, and maturation of exocrine vesicles, and secretion in response to
stimulation. The regulatory networks that drive expression of these genes is
practically unknown. In order to identify multiple important genes, a systems
biology approach could be taken, where expression is profiled across
differentiation in order to identify differentially expressed genes in fully developed
cells versus the immature cells in the embryo.
Currently, most profiling studies involve measurements of tens of thousands of
genes which is far more than current statistical and mathematical modeling
approaches can handle as far an integrating all of these components into
networks that can describe the whole system. Additional strategies need to be
developed that can build hypothesis driving networks or narrow down gene lists
to focus modeling on only important subsets.
One way to statistically identify pathways that are involved in biological functions,
based on large numbers of measurements, is to use a gene ontology enrichment
25

analysis [86, 87]. This is a bioinformatics approach which tests for over or
underrepresentation of gene ontology (GO) terms in a set of expressed genes.
The percentage of genes in each GO terms is compared to a background set
(such as the whole genome), which is assumed not to have any bias.
Currently there are several knowledge-based algorithms that predict interactions
between genes or gene products based on curated databases developed from
literature searches. These programs can be used to filter for many different types
of interaction (i.e. enzymatic, protein binding, and transcriptional regulatory). If,
for instance, a profiling experiment measures RNA expression changes across
several conditions, then filtering for transcription regulatory interactions will
probably be the most relevant to that dataset. The direction of the interaction as
well as whether it is activating or inhibiting is also predicted.
In these programs, gene lists of interest (i.e. differentially expressed genes) are
uploaded and used as "seed nodes." These are the nodes from which networks
can be built by adding "edges" between then, signifying an interaction. Several
algorithms are available to generate networks from these nodes. For instance,
Metacore's "Expand by One Interaction" builds a one-step network around a
selected seed node by adding all direct upstream and downstream effectors.
Filters can be used to only add genes based on certain criteria (i.e. interaction
type, and membership in a gene list of interest). In this way networks can be built
one interaction at a time from a list of differentially expressed genes [88].
1.6 MicroRNAs and Cell Differentiation
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1.6.1 MicroRNAs
MicroRNAs (aka microRNAs) are small (22-23 nt) endogenous noncoding RNAs
which are important regulatory molecules in the cell. They work in the cytoplasm
to post-transcriptionally repress gene expression. They act by "targeting" mRNAs
through partial base complementarity, usually in the 3'UTR but target sites have
also been found in the coding region and 5'UTR. Once targeted, an mRNA is
directed to translational inhibition and increased degradation due to message
instability. This leads to a decrease in protein expression. Analysis of the human
genome has found that most mRNAs contain conserved microRNA target sites.
A mRNA may be targeted by many microRNAs and a single microRNA member
can have many potential targets, indicating that microRNA based silencing is a
common mechanism that participates in numerous functions [89, 90].
MicroRNAs were first identified a little more than 20 years ago in C. elegans, and
have since been found throughout the animal kingdom. Several thousand have
been identified so far in humans, with most having homologous sequences in
mice and rats.
Processing of mature microRNAs is a multistep process that begins with the
transcription of an initial long RNA, known as pre-microRNA [91]. This premicroRNA is transcribed by RNA polymerase II [92] from its own gene. There are
also clusters of microRNAs in the genome which are expressed as a single
polycistronic transcript. The pre-RNA is then cleaved in the nucleus by the
RNaseIII enzyme DROSHA to become ~70bp transcripts called pri-microRNAs,
which contain a stem-loop structure. There are also microRNAs which are
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processed from the introns of host mRNAs. These RNAs (known as "mirtrons")
generally bypass DROSHA processing [93]. Pri-microRNAs are then exported to
the cytoplasm via the nucleoprotein exportin-5 [94]. The cytoplasmic primicroRNA is then process into a mature single stranded microRNA by another
RNaseIII enzyme, DICER. The mature microRNA is then loaded into the RNAinduced silencing complex (RISC), a riboprotein complex which can then target
mRNAs for silencing.
Interestingly, recent attention is being paid to microRNAs outside the cell. These
small RNAs have been found in plasma, milk, and saliva, specifically they are
mainly found in exosomes which are nano-sized membrane bound vesicles
secreted by many different cell types into the extracellular matrix [95, 96]. These
microRNAs have been found to be transferred between cells, and could be
serving as some form of cellular communication, and clinically they could be
used as biomarkers [97, 98].
The exact mechanism(s) by which microRNAs exert their repressive functions in
vivo are still being worked out. Uncertainty in this area stems from the fact that
the RISC can both repress translation and facilitate mRNA instability. Some of
the earliest studies highlighted the role of microRNAs as translational repressors.
In fact the first microRNA discovered, lin-4, seems to work exclusively under this
model by repressing lin-14 protein expression without any appreciable change in
mRNA [99]. However, this has come to be viewed as the exception rather than
the rule as many subsequent studies identified a role for microRNAs in mRNA
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degradation, and large scale studies have found that degradation explains most
of microRNA repression.
In a recent model proposed by Elchhorn et. al. [100], translational inhibition and
degradation occur sequentially with inhibition occurring first followed by
degradation due to deadenylation. At steady state conditions degradation
predominates, and inhibition only plays a significant role in cells where transcripts
with short poly-A tails are stabilized.
These observations have biological as well as experimental implications.
Degradation means that microRNAs induce permanent changes of gene
expression that cannot be reversed. This also means that measuring changes in
mRNA expression will capture most of the effect of a microRNA, and large scale
techniques such as microarrays and RNAseq can be used in identify microRNA
targets based on their changing expression.
Soon after microRNAs were identified, much work was done to characterize and
predict their target sites, as this is the first step in identifying their biological
function. Unlike plant microRNAs, animal microRNAs only share partial
complementarity with their target making identification difficult. Extensive
mutation studies were carried out on known microRNA:mRNA target pairs in
order to identify necessary features. The essential element for microRNA
targeting is the "seed" sequence located at the 5' end of the microRNA. It is
comprised of either 6, 7, or 8 nt that are complementary to the target, although
sometimes 3' pairing (particularly nucleotides 13-16) [101] can be used to
compensate for a weak seed sequence [102]. Beyond sequence
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complementarity there are several other factors that influence targeting
efficiency. Local AU composition was found to be higher immediately
downstream of the mRNA target sites [101]. Microarray analysis showed that GC
rich regions were less likely to be true targets despite seed region pairing. Also,
although target sequences have been found in many transcript regions, true
target sites are most likely in the 3'UTR. This is thought to be due to the fact that
the ribosome can displace the RISC as it translates the protein, rendering it
ineffective.
Using these rules, many algorithms have been developed to identify putative
target sites in available genomes and refseq transcripts [103]. Along with
sequence pairing, and AU content, many of these programs also take into
account conservation of predicted targets across species as an indication of
function. Despite the fact that these programs are developed around a similar set
of principles, many of their predictions do not overlap, conclusive measurements
of their sensitivity and specificity have not been made, and there is currently no
gold standard prediction program [104, 105]. Because of this, data driven
evidence is essential to supplement predictions in order to identify true target
sites.
1.6.2 MicroRNA Functions in Development and Differentiation
Many studies have pointed to the role of microRNAs in cell fate decisions.
Knockout mouse models have produced defects in both maintenance of stem cell
identity, and in the progression of pluripotent cells into a differentiated phenotype
[106]. For instance, global microRNA knockouts in mouse ES cells have defects
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in differentiation (when either Dicer or the RNA binding protein DGCR8 is
removed in ES cells, mature microRNAs can no longer be expressed). While this
technique is not specific, it has proven useful in studying microRNA function.
Unfortunately, knocking out single microRNAs often shows no phenotype. This is
thought to be due to target overlap in many microRNA families (microRNAs
which share the same seed sequence), and the fact that most mRNAs are
thought to be targeted by many microRNAs. This redundancy often makes single
knockouts uninformative.
In the microRNA knockouts, ES cells no longer express lineage specific markers
under differentiation conditions, and they are not able to down-regulate
pluripotency factors such as Klf4, and Oct4. Interestingly, in one study, chimeric
mice could not be generated by injecting dicer null ES cells into wild type
blastocysts indicating a deficiency in differentiation [106].
Tissue specific Dicer knockouts have also been developed, and have identified
roles for microRNAs in the differentiation of many cell types including muscle
cells, neurons, pancreatic islet cells, osteoblasts, oligodendrocytes, and many
others [107]. Subsequent studies, following up on these observations have been
able to identify functions of specific microRNAs in differentiation. Studies in
muscle, for instance, have revealed an extensive regulatory network composed
of both microRNAs and transcription factors that control several functions in
differentiating myoblasts, from proliferation to cell fate [108-110].
In the salivary glands, relatively little is known about the contribution of
microRNAs to development or differentiation. Several profiling experiments have
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been performed on both epithelial and mesenchymal cells during branching
morphogenesis [111, 112] but no such studies have been done focusing on
acinar cell differentiation. Of the profiling experiments that have been done, many
expression changes have been measured, but functions have only been
described for a few microRNAs.
In the early branching epithelium of the SMG, a panel of microRNAs were
measured in the end buds and primary duct. Expression was compared between
the two regions under the hypothesis that microRNAs could be important for
spatially controlled gene expression. By using antagomiRs in ex vivo cultures
they were able to identify functions for several microRNAs. Knockdown of either
mir-200c or miR-34a, which are both highly expressed in the end buds, increased
the number of end buds, while knockdown of miR-204 or miR-135, both highly
expressed in the main duct, decreased branching.
1.7 Specific Aims
Understanding the process of acinar cell terminal differentiation in vivo is vital to
better control cell differentiation in vitro for the purpose of tissue regeneration and
artificial gland construction. In the parotid gland of the rat acinar cells are a single
type (serous). This pure cell population could be used as a model of
differentiation in vivo. In rats, terminal differentiation occurs largely postnatal. The
acinar cells morphological changes such as expanded Golgi complex and rough
ER, and the accumulation of secretory granules in the apical cytoplasm. The
mechanisms that drive these changes remain largely unstudied in the salivary
glands, and transcription factors required to activate expression of parotid
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specific terminal differentiation markers is unknown. Currently, the ability to
generate gland tissue for patients suffering from hyposalivation is not available.
Loss of acinar cells is a major factor for these patients and the ability to
differentiate acinar cells in culture could be used to grow transplantable tissue for
patients.
To address this gap in knowledge, I will use a Systems Biology approach to
model gene regulatory networks driving differentiation. I will profile mRNA and
microRNA expression across parotid acinar cell terminal differentiation and use
network analysis to identify putative transcription regulatory and
microRNA:mRNA interactions. Thus I will be able to derive a network driving
expression of terminal differentiation markers. The regulatory transcription factors
and microRNAs in the network could then be investigated in vitro for their ability
to control differentiation.
Aim 1 will profile the expression of mRNAs and microRNAs across acinar cell
terminal differentiation. Many profiling experiments in the salivary glands have
focused on branching morphogenesis, which begins relatively early in
development, and does not have much overlap with differentiation, particularly of
acinar cells. In the parotid, acinar cell differentiation occurs mostly postnatal, and
there is a dearth of knowledge about the gene expression changes that take
place during this time period. In this study, both mRNA and microRNA
expression was measured at multiple time points spanning terminal
differentiation. By using laser capture, measurements were restricted to the
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acinar cell lineage. By comparing expression between different stages,
molecules that are important for driving differentiation can be identified.
Aim 2 will predict a gene regulatory network driving acinar cell differentiation.
Profiling experiments are likely to produce thousands of differentially expressed
gene. In this aim, several strategies were employed to identify likely functions,
predict interactions, and incorporate genes into regulatory networks. Clustering
and regression analysis was used to identify prevailing patterns of gene
expression, followed by enrichment analysis to identify contributing biological
processes. Interactions between genes of interest and subsequently a gene
regulatory network was predicted using the knowledge-based program Metacore,
sequence-based predictions, and our own expression measurements.
Aim 3 will validate successive edges of the regulatory network, and investigate
the ability of network transcription factors to drive differentiation in vitro. One of
the main goals of using systems biology to study the salivary glands is to be able
to use the knowledge gained to control aspects of development, and to aid in
potential clinical solutions such as regeneration or artificial gland construction. In
this last section we address the hypothesis that interactions from the proposed
regulatory network can be used to drive expression of terminal differentiation
genes in de-differentiated cells. We will also use these cells to validate multiple
steps in our network.
In this study we were able to identify thousands of differentially expressed
mRNAs during differentiation, and dozens of regulated microRNAs many of
which have not been studied in acinar cell differentiation. Using these
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measurements we developed a gene expression network model incorporating
both transcription factors and microRNAs driving expression of terminal
differentiation markers, genes that would need to be expressed in regenerated or
regrown acinar cells [113, 114]. We validated several of these network
interactions in ParC5 cells, a model of dedifferentiated parotid acinar cells.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Animals/Tissue Dissection
Parotid tissue was obtained from Sprague Dawley rats (Harlan laboratories) at 9
time points spanning development of the parotid gland, including embryonic day
18 (E18), E20, postnatal day 0 (P0; which is E22), P2, P5, P9, P15, P20, and
P25.
Ethics Statement: This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by the Institutional
Animal Care and Use Committee of the University of Louisville (Protocol Number:
11059).
Timed pregnant females were used for the embryonic and early postnatal time
points. Birth (P0) in this strain is typically on E22. All animals were euthanized by
carbon dioxide inhalation and decapitation of embryos following IACUC-approved
procedures. For animals older than P5 the parotid gland was removed,
embedded in Tissue-Tek CRYO-OCT Compound (Fisher Scientific) and
immediately frozen with a mixture of dry ice and 100% 2-methylbutane. For the
embryonic and earlier postnatal time points, heads were divided along the
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sagittal plane, and each half was embedded upright. All tissue blocks were
stored at -80°C.
2.2 Laser Capture Microdissection
For cryosectioning, blocks were thawed to -30°C. Sections (7 µm) were taken
with a Leica cryostat onto clean chilled slides that had been treated with
RNaseZap (Ambion), and immediately fixed in 70% ethanol. Xylenes and 100%
ethanol were used to remove OCT before staining. For the embryos, tissue was
sectioned and stained with hematoxylin and eosin (H&E) until the parotid gland
was located. All tissue sections were lightly stained with H&E to identify acinar
cells based on the structure of the cells and local vascular landmarks, as
validated by immunofluorescence staining of previous samples using anti-parotid
secretory protein antibody. Stained sections were dehydrated by washing in
100% ethanol and xylenes before being used for microdissection.
Laser capture microdissection (LCM) was performed on an Arcturus PixCell IIe
LCM System (Life Technologies/ Thermofisher Scientific) [115, 116]. Caps
containing CapSure transfer film carrier were applied to the tissue and cells were
adhered to the cap using laser pulses. The cap was then visually inspected
under the microscope to ensure that contaminating cells were removed. Only
caps that did not contain any detected extraneous tissue, were used in
subsequent experiments. Because extracting intact RNA is difficult in RNaseI rich
tissues, the aqueous staining steps were kept short (15 – 30 seconds), and no
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more than 150 laser pulses were used when capturing tissue in the older animals
when RNaseI expression is high.
2.3 RNA Isolation, microarrays, and qPCR arrays
RNA was isolated from the LCM caps using the RNaqueous micro kit (Ambion),
per the manufacturer’s instructions. Briefly, once cells were isolated onto an LCM
cap, lysis buffer was applied immediately. Tubes were then incubated in a heat
block at 42°C for 30 min. The lysates were either processed immediately or
stored at -80°C. Lysates from multiple caps of the same sample, taken on the
same day were combined before proceeding with isolation. At least three
independent biological samples (from separate litters) were used for isolation of
total RNA at each of the 9 time points. Quantity and quality of the total RNA was
assessed using a 2100 Bioanalyzer (Agilent). Samples with a RIN value of at
least 7 were used.
For analysis of mRNA expression, the Whole Transcriptome-Ovation Pico RNA
amplification system (NuGen Technologies Inc.) was used to prepare amplified
cDNA from total RNA for 9 time points of the developing parotid acinar cells. The
biotin-cDNA was hybridized to 27 separate rat genome 230 2.0 Affymetrix
GeneChips, having 31,099 probe sets.
MicroRNA expression was measured by qRT-PCR at four time points during
acinar differentiation: E20, P5, P15, and P25. A total of 372 primer pairs
(miRCURY LNA, Exiqon) were used which amplify well annotated rodent
microRNA sequences. Triplicate samples were run for each time point. Total
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RNA (1 ng) was used to synthesize cDNA (Exiqon’s Universal cDNA Synthesis
Kit). The cDNA was then applied to microRNA Ready-to-Use PCR, Mouse&Rat
panel I, V1.M (Exiqon) per the manufacturer’s instructions. Briefly, each 20 µl
cDNA reaction was diluted 110x in nuclease free water and then combined 1:1
with 2x SYBR green master mix. The reactions were run on an ABI 7500 RTPCR system.
2.4 Statistical Analysis of Array Data
2.4.1 Normalization and Filtering
The processing and analysis of the data was carried out in R, and the code used
can be found in the supplementary material in Metzler et. al. [114].
mRNA: The data were normalized using the rma function in the Bioconductor
package affy [117], with the default settings. Quality was also checked using
PCA analysis (Partek). Probes were then filtered according to the following
criteria: 1) required mapping to an Entrez Gene ID, 2) removal of duplicate
probes which map to the same Entrez Gene ID. To focus on genes involved in
the process of differentiation, probes with variability below the 50th percentile
across all samples (as measured by the interquartile range) were removed. Data
filtering was done using the nsFilter function in the Bioconductor package
genefilter [118].
microRNA: microRNAs were removed that had >50% missing data (i.e.
expression was not detected in seven or more samples, which excluded 100
microRNAs), missing values from remaining probes were imputed using R
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function imputeKNN in Bioconductor package MmPalateMicroRNA [119](14.5%
of values were imputed) [120]. A median sweep was performed to normalize
delta Ct values by subtracting the global median for each array.
2.4.2. Hierarchical Clustering
microRNA: Differentially expressed microRNAs were clustered using the hclust
function (hierarchical clustering) in the stats package in R. Distance d was
calculated based on the correlation coefficient r, with d= 1-r. A heatmap was
generated from the microRNA clusters using the heatmap_2 function in the
Bioconductor package Heatplus
2.4.3 Differential Expression
mRNA: Normalized log2 values were used for analysis. One-way ANOVA was
used to identify differential expression of mRNA, with a false discovery rate
(FDR) correction to account for multiple tests [121]. A p-value < 0.05 was
considered significant. Comparisons were also made between adjacent time
points by empirical Bayes t-tests using the Bioconductor package limma [122].
microRNA: Normalized -ΔCT values were used for analysis of microRNA results.
Differential expression was analyzed by one-way ANOVA and also by FDR
corrected empirical Bayes t-tests comparing pairs of time points.
2.4.4 Expression Patterns and Regression Analysis
Having several time points of measurements allows the identification of dynamic
and complex patterns of mRNA and microRNA expression over time. We
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extended this by the independent approach of k-means clustering of the pergene scaled expression data (function kmeans in R package stats). In addition,
regression analysis was used to identify genes that significantly fit into either
linear, quadratic, or cubic trends. The trends were then grouped into clusters.
2.5 Network Analysis
All differentially expressed mRNAs were uploaded into Metacore (Thomson
Reuters Inc., Carlsbad, CA). Markers of terminal differentiation with increasing
expression (i.e. PSP, amylase) were used as initial nodes. The neighborhood
around each of these nodes was explored using the expand function to identify
possible regulating factors. DE genes in the neighborhood were kept for another
round of expanding only if their expression pattern over time was consistent with
the reported interaction (i.e., activating vs. repressing) and the pattern of the
target gene. The expand function was used iteratively until no further DE genes
were identified. microRNAs predicted to target any nodes were incorporated into
the network when their expression patterns had an inverse correlation with the
pattern of the target mRNA.
2.6 Cell Culture: Treatments and Transfections
ParC5 and the closely related ParC10 cells are derived from rat parotid acinar
cells, and were obtained as a generous gift from Dr. Quissell's laboratory. These
cells were maintained at 37°C and 5% CO2 in media as described by [63], and
split regularly using 0.25% trypsin EDTA.
2.6.1 Luciferase Assays
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Promoter activation: Standard methods were used to clone the target gene
promoters upstream of luciferase in pGL4.10 vector. Expression plasmids for
selected transcription factors were from OpenBiosystems (Huntsville, AL) or
Thermoscientific (Waltham, MA) or were cloned by RT-PCR of rat genomic DNA
into pCDNA4. Luciferase reporter plasmids were transiently transfected (list of
primers used for cloning can be found in the appendix). Lipofectamine
(Invitrogen) was used for luciferase promoter studies. From previous optimization
performed in the lab pertaining to ParC5 cells, a Lipofectamine to DNA ratio of
8ul/1ug DNA was used. Cells were plated in 6-well plates at 100,000 cells per
well and grown overnight before transfection. Cells were transfected with
2ug/DNA per well. 1ug of luciferase reporter was used, and 50ng of the renilla
luciferase (Rluc) expression vector PGL4.73. Several concentrations of
expression vector containing the transcription factor of interest were used, and
any difference in DNA amount was made up with the vector Bluescript II. The
Mist1 transcription factor expression clone was in pcDNA4 vector, and the
spliced Xbp1 (Xbp1-S) expression vector was pFLAG.Xbp1p.CMV2 (Addgene;
Cambridge, MA). In all experiments, pGL4.73-Renilla luciferase plasmid was cotransfected as an internal control for normalizing transfection efficiency. 48 hours
after transfection, cell extracts were prepared using Passive lysis buffer
(Promega) and assayed for both firefly and Renilla luciferase activities using the
Luciferase Assay and Renilla Luciferase Assay Systems from Promega with a
Berthold Lumat LB9501 luminometer. For each experiment, triplicate wells were
used to measure normalized luciferase expression (the ratio luciferase/renilla aka
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luc/ren) under an experimental condition (expression vector containing the
transcription factor of interest), and a control condition (an empty vector). Each
experiment was repeated at least three times. A student's t-test was used to test
for differential expression between the experimental and control conditions after
combing experiments (a p-value of < 0.05 was considered significant).Results
are given as means ±SEM.
3'UTR assays: microRNA mimics (Dharmacon, Lafayette, CO) were transfected
at 10 pmols/well along with 100 ng of a luciferase reporter (PGL4.25) which
contained either a 3'UTR of interest downstream or no 3'UTR.DharmaFeCT Duo
(Dharmacon, Lafayette, CO). ParC5 cells were plated in 24-well plates at 25,000
cells/well and were grown overnight before transfection. 3'UTRs were cloned
down-stream of firefly luciferase cDNA in PGL4.25 using XbaI and FseI. Primers
used to clone 3'UTRs from rat DNA are listed in the appendix. Renilla luciferase
plasmid (PGL4.73) (5ng/well) was used as a transfection efficiency control. et. al.
For each experiment (in triplicate) luc/ren expression was measured under four
conditions.

Condition

Treatments

notes

1

microRNA of interest +
Pgl4.25-3'UTR

2

microRNA of interest +

Expression will reflect

PGL4.25-empty

any effect of the
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microRNA on the empty
vector
3

Control microRNA +

Expression will reflect

PGL4.25-3'UTR

the effect of microRNA
transfection

4

Control microRNA +

Expression will reflect

PGL4.25-empty

any effect of the control
microRNA on the empty
vector

In order to control for a microRNA specific effect on the empty vector, the
following ratios were used to normalize expression.

𝐿𝑢𝑐𝐸 =

𝑙𝑢𝑐
(𝑟𝑒𝑛) 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛1(𝑚𝑖𝑐𝑟𝑜𝑅𝑁𝐴 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡 + 𝑃𝐺𝐿4.25_3′𝑈𝑇𝑅)
𝑙𝑢𝑐
(𝑟𝑒𝑛) 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑠2(𝑚𝑖𝑐𝑟𝑜𝑅𝑁𝐴 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡 + 𝑃𝐺𝐿4.25𝑒𝑚𝑝𝑡𝑦)

Where 𝐿𝑢𝑐𝐸 is the normalized luciferase expression in the experimental condition
(transfection of a microRNA mimic that is predicted to target the cloned 3'UTR).
𝑙𝑢𝑐
) 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛3(𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑚𝑖𝑐𝑟𝑜𝑅𝑁𝐴 + 𝑃𝐺𝐿4.25_3′𝑈𝑇𝑅)
𝑟𝑒𝑛
𝐿𝑢𝑐𝐶 =
𝑙𝑢𝑐
(𝑟𝑒𝑛) 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑠4(𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑚𝑖𝑐𝑟𝑜𝑅𝑁𝐴 + 𝑃𝐺𝐿4.25𝑒𝑚𝑝𝑡𝑦)
(

Where 𝐿𝑢𝑐𝐶 is the normalized luciferase expression in the control condition
(transfection of a control microRNA that does not target the cloned 3'UTR).
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This normalization results in measurements that are the ratio of a ratio. In order
to test the null hypothesis that there is no difference between 𝐿𝑢𝑐𝐸 and 𝐿𝑢𝑐𝐶 , a tstatistic was calculated as in Jacobs et. al. [123].

𝑡𝐿𝑢𝑐𝐸 ,𝐿𝑢𝑐𝐶 =

𝐿𝑢𝑐𝐸 − 𝐿𝑢𝑐𝐶
√

2
2
𝑠𝐿𝑢𝑐
𝑠𝐿𝑢𝑐
𝐶
𝐸
+
𝑛𝐿𝑢𝑐𝐸 𝑛𝐿𝑢𝑐𝐶

Where s2 is the variance and n is the number of experiments. Experiments were
repeated at least three times, and p-values were determined from a t-statistic
table.
2.6.2 Tunicamycin Treatments and qPCR
Tunicamycin was kept in a stock concentration of 2mg/ml in DMSO. ParC5 cells
were treated with either 1µg/ml tunicamycin or an equal concentration of DMSO
for eight hours. Media was then removed and replaced, and the cells were
allowed to recover overnight. For siRNA pretreatment, cells were transfected with
a siRNA pool targeting Xbp1 (Dharmacon, L-085513-02-0005) or a pool of
control (non-targeting) siRNAs 24 hours before tunicamycin treatment. siRNAs
were transfected at 100nM/well using 8ul of Dharmafect duo per well.
RNA isolation was performed using Trizol. Concentration and quality were
assessed by nanodrop. cDNA was synthesized using the High Capacity cDNA
Synthesis Kit (ThermoFisher Scientific) per the manufacturer's instructions.
qPCR was carried out using Taqman primer/probes (a list can be found in the
appendix). RPLP2 was used as an endogenous control and relative expression
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was analyzed using the 2^-ΔΔCT method [124]. Experiments were performed at
least three times and a t-test was used to compare gene expression between the
control condition (i.e. DMSO treatment, control siRNA) and the experimental (i.e.
tunicamycin treatment, Xbp1 siRNA).
2.7 Appendix
Table 2.1: Cloning primers
Target

Primers

Gene
Sox11
3’UTR

For: 5' cacctctagaATAGAGTTTGCATGCCAGCG 3'
Rev: 5'
acaaggccggccacaattcgaaCCTCTGTGAAAAACTCCTGC 3'
For: 5’ caccttcgaaGCATAGGCAAGGTATAGAGG 3’
Rev: 5’ caccggccggccGAGATCCGTCATGATACGAC 3’

Xbp1
3’UTR

Klf4 3’UTR

For: 5’ cacctctagaTCTTAGAGATCCCCTCTGAG 3’
Rev: 5’ caccggccggccGCCAGGCTGAACGATAACTG 3’
For: 5’ cacctctagaATTCCACATCGTGGACATGAC 3’
Rev: 5’ caccggccggccTGCTTAAAGGCATACTTGGG 3’
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s-XBP1
cDNA

For: 5' CACCGCGGCCGCATGCTTGTGGTGGCAGCGG 3'
Rev: 5'
CACCGGGCCCGGCTCTTTAGACACTAATCAGCTGGG 3'

Mist1
Promoter

For: 5' GGTACCGCAGCCATGTGGTTGG 3'
Rev: 5' CTCGAGCACGGGGGACAAGGACACG 3'

-515 to
+39
500bp
PSP

For: 5' CACCGGTACCCATTATTGCCTCCTCCCAG 3'
Rev : 5' GGTGCTCGAGGACAGGAAAGCCTTGTTTC 3'

promoter
-500 to +
21
1kb PSP
promoter

For: 5' CACCCCTTCTCTCGTCACTGAAATGTTTTC 3'
Rev : 5' GGTGCTCGAGGACAGGAAAGCCTTGTTTC 3'

-1041 to
+21
1.5kb PSP

For: 5'

promoter

CACCGGTACCGCTTGGCAGACATGAGATGGAAATCG 3'
Rev : 5' GGTGCTCGAGGACAGGAAAGCCTTGTTTC 3'
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Intron PSP

For: 5' CAACTTGTCGACCTTGTGGTCTTGTGTGGC 3'
Rev: 5' CATTGGTCGACAGCCCAGCTTGAAGATCC 3'

Table 2.2: Taqman primers for qPCR

Gene
Xbp1
Mist1 (aka Bhkha15)
Rab3d
Rab26
PSP

Taqman Primers
Rn01443523_m1
Rn00563466_m1
Rn00756153_m1
Rn00592144_m1

Custom primers
For: TTCCCTTCGTCAACCGTATTC
Rev: CCCTGAATAGCACTTCCACTC
Probe: AAACATCCTATGCCCAGTGCTCCA

Connexin 32
Tcf3
Rplp2

Rn01419045_m1
Rn01452748_m1
Rn01479927_g1
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CHAPTER 3: MRNA AND MICRORNA EXPRESSION CHANGES DURING
PAROTID ACINAR CELL DIFFERENTIATION
3.1 Introduction
During the postnatal period of salivary gland development, the acinar cell
population expands and these cells mature to the fully differentiated phenotype.
Drastic changes in cell morphology as well as gene expression occur. It is during
this period that acinar cells gain expression of lineage specific genes such as
salivary amylase (Amy1a) and the parotid secretory protein (PSP), which are
recognized as terminal differentiation markers of parotid acinar cells. The
activation of these genes is necessary for the cells to become fully differentiated,
however, there is little knowledge about what is driving acinar-specific gene
expression. Changing expression has only been studied for a handful of genes
during differentiation, and very few studies have measured regulatory molecules
such as transcription factors. No large scale profiling experiments have been
reported during the last stages of salivary gland development, when terminal
differentiation is occurring.
By measuring global mRNA and microRNA expression at multiple time-points
during acinar cell differentiation, a whole host of differentially expressed genes
can be identified including those involved in the regulation of gene expression.
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This study also makes use of laser-capture microdissection (LCM) to specifically
isolate acinar cells. Whole salivary glands are a mixture of many different cell
types including both epithelial and mesenchymal. The mesenchyme cap that
encloses the gland contains both neuronal and endothelial cells. Within the
epithelium itself there are both ductal and acinar cells, as well as some
myoepithelial cells. By combining histological stains with LCM, acinar cells can
be differentiated and isolated away from the ductal cells. Acinar and immature
pro-acinar cells can be isolated in this way from many different time points during
differentiation. For the measuring of mRNA, cells were isolated from nine time
points in triplicate. Two embryonic time points (E18 and E20). Based on
morphological studies these represent very immature cells. They have very few
electron dense granules (and many cells have none), no lumen, no cellular
polarity, and the expression of many cargo protein is undetectable. Six postnatal
time points were also measured (P0, P2, P5, P9, P15, P20, and P25).
Analysis of this data revealed thousands of differentially expressed genes, and
complex patterns of expression. Enrichment analysis of gene clusters points to
the role of ER signaling and the adaptive unfolded protein response in the
expression of lineage specific genes. We also identify a novel role for the
transcription factor PPARg, which is involved in the differentiation of other cell
types but has not been studied in the salivary gland.
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Dozens of differentially expressed microRNAs were also identified. By integrating
these two data sets, microRNA:mRNA interactions were identified which could be
important for driving differentiation.
3.2 Results
3.2.1 mRNA Expression
Using laser-capture microdissection, acinar cells could be isolated from glands at
multiple ages without any detectable contamination from ductal cells (Figure 3.3).
High quality RNA could be obtained from these cells, as measured by
Bioanalyzer. This was especially important to determine as the mature gland
expresses high levels of RNaseI which could easily lead to degraded samples
not suitable for microarray. By reducing the time spend in the aqueous phase
during staining, and using a limited number of laser pulses per slide, a RIN (RNA
integrity number calculated by measuring the ratio of the 18S and 28S peaks) of
at least 7 out of a possible 10 could be obtained (Figure 3.2). This is generally
considered suitable for microarray analysis.
Once RNA was obtained and cDNA generated (see methods), expression was
measured by hybridizing to the Affymetrix rat genome array 230, which contains
> 30,000 probe clusters.
In order to detect a potential batch effect in the microarray measurements,
principal component analysis (PCA) was used to identify the main source of
variation, which should be the age group of the sample and not the batch in
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Figure 3.1 Isolation of Acinar Cells by Laser Capture Microdissection. A
representative image is shown of a Parotid section from an embryonic day 20
(E20) sample, and a postnatal day 25 (P25) sample. Tissue was stained with
H&E. Panels on the left show the section before capture which contains acinar
cells (arrow) and surrounding cell types including ductal cells (star), and
connective tissue (arrow head). On the right the film-covered caps are shown
after the acinar cells have been captured and the sample is now devoid of
surrounding tissue.
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4.
3.

1.
2.

Figure 3.2 Quality RNA Could be obtained from Acinar Cells. Once acinar
cells were isolated by LCM, RNA was extracted and quality was assessed by
Bioanalyzer (Agilent). This figure shows representative traces for four of the time
points isolated: embryonic day 20 (E20), postnatal day 5 (P5), postnatal day 15
(P15), and postnatal day 25 (P25). There are four main peaks on a trace, labeled
from left to right on the top left panel. 1.) Control peak introduced in the dye
mixture. 2.) 5S RNA and tRNA. 3.) 18S RNA. 4.) 28S RNA. The RNA Integrity
Number (RIN) ranging from 1 to 10 is used to assess quality. The higher the
number the less degradation is present. A RIN of 7 or more is considered
adequate for microarray and qPCR measurements.
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which it was run. The first three principal components for each sample were
plotted on an x-y-z axis (Figure 3.3). The samples mostly cluster based on their
age group, indicating that the batch had little effect on expression variation, and
these measurements were carried forward for further analysis.
The measurements were normalized, filtered, and used for significance testing
(see methods for the detailed procedure). An overview of the resulting analysis is
shown in Table 3.1. 2565 differentially expressed genes were identified by an
analysis of variance. In order to validate these expression changes, several of
these genes were assayed by qPCR, considered the gold standard of microarray
validation. The three gene (Xbp1, PSP, and Nupr1) were measured in all nine
time points, and their expression pattern correlated with the microarray
measurements (Figure 3.4).
While significance by ANOVA indicates regulated expression changes between
some of the time points measured, it does not reveal the direction or the timing of
such changes. To identify possible temporal specific patterns across all of the
differentially expressed genes, hierarchical clustering was used to group the
ages based on patterns of gene expression and the resulting heatmap can be
seen in Figure 3.5.
From this analysis (Figure 3.5), four stages are evident during differentiation: An
embryonic stage (E18, E20, and P0), early postnatal stage (P2, and P5), mid
postnatal stage (P9 and P15), and a late stage (P20 and P25). Fewer gene
expression changes occur between time points within a stage, but there are
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Figure 3.3 Principal Component Analysis (PCA) was used to identify
potential batch effects in our microarray data. The first three principal
components (PC) were plotted for each sample on an X-Y-Z axis and a view
showing the first two PCs is shown in (A.). Points are color coordinated based on
their age group. An arrow overlaying the points indicates the progression through
time starting with the E18 samples (red) and ending with the P25 samples (gray).
The samples largely cluster based on age as expected rather than batch.
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Figure 3.4 Microarray Validation by qPCR. Taqman qRT-PCR was run on
triplicate RNA samples spanning nine time points of parotid acinar differentiation,
using primers that amplify Psp, Xbp1, and Nupr1. Expression of Rplp2 was used
for normalization. The expression profiles (plotted in Log base 10) replicate the
increase in expression seen in the microarrays
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Figure 3.5 Heatmap of Differentially Expressed Genes Identifies Four
Stages During Acinar Cell Differentiation. Hierarchical clustering was used to
group ages based on the similarity of their gene expression profile for the 2556
differentially expressed genes identified by ANOVA (Table 3.1). Distance was
calculated as dissimilarity (1-r) (r=correlation coefficient). A heatmap was then
constructed from the resulting dendrogram by scaling gene expression across
the time points measured, and coloring them based on their relative expression
(red=low expression, and yellow=high expression). This resulted in the
identification of four main stages where relative gene expression (represented by
color) remains largely constant within a stage but changes dramatically between
stages.
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Comparison
ANOVA (all nine time-points)
E18 vs E20
E20 vs P0
P0 vs P2
P2 vs P5
P5 vs P9
P9 vs P15
P15 vs P20
P20 vs P25
Stage 1 vs Stage 2
Stage 2 vs Stage 3
Stage 3 vs Stage 4

Number of Differentially Expressed
Genes
2656
2
3
57
0
2
13
48
93
604
124
992

Table 3.1: Differentially Expressed Genes during Acinar Cell Terminal
Differentiation. The number of differentially expressed genes was determined
between adjacent time-points and between all combinations of comparisons by
ANOVA. We also determined the number of differentially expressed genes
between stages as identified in Figure 3.5. Stage 1: E18, E20, and P0; Stage 2:
P2, and P5; Stage 3: P9, and P15; and Stage 4: P20, and P25.
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many expression changes between stages. This is also evident from the pairwise
comparisons between adjacent time points (Table 3.1). A t-test was used to
identify both up and down-regulated genes. Only three genes are differentially
expressed within the embryonic stage (E18vsE20 and E20vsP0), while in the
period immediately after birth (P0vsP2) many genes are up-regulated. There are
also many differentially regulated genes between later time points.
We next wanted to be able to identify possible biological processes and
pathways that contribute to gene regulation. For large unbiased datasets a
common method is to use Gene Ontology enrichment analysis. This will identify
over represented processes that are specific to the biological system under
study. In order to focus the identification of processes on specific expression
patterns the differentially expressed genes (Figure 3.5) were clustered based on
their pattern across differentiation. This would also presumably make the
analysis more robust, as an unclustered dataset would contain a mixture of
expression patterns and their corresponding pathways, and ultimately the
underlying assumption of this approach is that there is a common pathway
regulating genes with similar expression profiles and term enrichment allows us
to make predictions about what those pathways are. The analysis resulted in the
identification of eight clusters (Figure 3.6).
The majority of genes are found in the first two clusters which are linear-like
patterns either continually decreasing (cluster #1, 1635 genes) or continually
increasing (cluster #2, 803 genes). Several clusters only contain a few members
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Figure 3.6 K-means Clustering Identifies Eight Patterns of Gene Expression
during Acinar Cell Differentiation. K-means clustering was used to group gene
expression into eight clusters. This analysis only included those genes
determined to be differentially expressed (Table 3.1). For the above graphs, gene
expression was standardized to a mean =0 and standard deviation =1. The red
line traces the average pattern for the cluster, and the grey lines are each
individual observation.
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(clusters # 3, 5, and 8) and were not considered for subsequent analysis.
Interestingly cluster #4 (106 genes) contains genes which are transiently
activated midway through differentiation, they increase in expression shortly after
birth, peak around P5 or P9, and then decrease back to basal levels. Genes in
cluster #6 (31) increase in expression only in the late stage, while genes in
cluster #7 (47) decrease in the late stage.
Enrichment analysis reveals that the genes in cluster #1 are enriched in terms
related to mitosis and the cell cycle (Table 3.2). These genes are progressively
decreasing across differentiation, and presumably genes promoting mitosis are
decreasing as these cells are exiting the cell cycle and becoming fully
differentiated.
Cluster #2 contains many of the previously identified acinar cell lineage specific
genes such as salivary amylase, PSP, DNase I, and Aquaporin 5 (Aqp5).
Processes enriched in this cluster could be involved in driving lineage specific
gene expression. Enrichment analysis on this cluster found an
overrepresentation of genes involved in ER-nucleus signaling and the adaptive
Unfolded Protein Response (UPR) (Table 3.4). In order to identify possible
transcription regulators in this cluster, enrichment of transcription factor targets
was tested. A knowledge-based program (Metacore) was used which curates
known transcription factor targets from the literature, and like GO enrichment can
perform an overrepresentation test on a set of genes. Three transcription factors
were identified (Table 3.3), two of which are present in the cluster (Xbp1, and
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Enrichment by Pathway Maps
Maps

FDR

Cell cycle_The metaphase checkpoint

6.777E-06

Cell cycle_Sister chromatid cohesion

5.312E-04

Cell cycle_Spindle assembly and chromosome separation

8.383E-04

Cell cycle_Role of APC in cell cycle regulation

8.839E-04

Development_NOTCH-induced EMT

5.959E-03

Cell cycle_Start of DNA replication in early S phase
Development_TGF-beta-dependent induction of EMT via
SMADs

6.013E-03

DNA damage_ATM/ATR regulation of G1/S checkpoint

1.772E-02

6.066E-03

Enrichment by GO Processes
Processes

FDR

mitotic cell cycle

1.867E-40

cell cycle

2.114E-33

cell cycle process

1.817E-30

cellular component organization

1.555E-23

cellular component organization or biogenesis

3.852E-23

cell division

2.537E-22

mitosis

1.751E-18

nuclear division

1.751E-18

cell cycle phase transition

7.557E-17

organelle organization

1.616E-16

Table 3.2: Processes Relating to Mitosis and the Cell Cycle are Enriched in
Cluster of Down-regulated Genes. Clustering differentially expressed genes
identified a cluster of 1635 continually decreasing genes (Figure 3.6, cluster #1).
GO enrichment analysis of this cluster identified many terms related to the cell
cycle. The top ten terms in GO Processes and Pathway maps is tabulated above.
The “Processes” column lists the process name and the “FDR” column lists the
FDR corrected p-value that DE cluster #2 is enriched in that term compared to a
background dataset (rat genome)
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Network
Object Actual n
Name
MIST1
XBP1
GCRalpha

5
20
85

719
719
719

R

9
114

N

Expected Ratio p-value

zInput IDs
score

12845 0.5038

5.654E9.925 05
6.522 1387212_at

12845 6.381

4.623E3.134 06
5.573 1371249_at
6.645E1.512 05
4.118

1004 12845 56.2

Table 3.3. DE Cluster #2 is Enriched in Targets for Mist1 and Xbp1.
Transcription factor enrichment analysis was run in Metacore on the 803 genes
in DE cluster #2. Enrichment is based on the number of downstream target
genes identified in the curated Metacore database. Affymetrix rat genome array
230 was used as the background dataset. The columns are as follows: Actual=
number of target genes in the dataset, n= number of network objects in the
dataset, R= number of target genes in the background set, N= number of
network objects in the background set, Expected= number of target genes
expected in the dataset, Ratio= Actual/Expected, p-value= FDR adjusted p-value.
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Enrichment by GO Processes
Processes

FDR

ER-nucleus signaling pathway

1.825E-04

cellular amino acid catabolic process

3.065E-04

response to endoplasmic reticulum stress

3.416E-04

alpha-amino acid catabolic process

8.107E-04

alpha-amino acid metabolic process

8.609E-04

organonitrogen compound metabolic process

1.173E-03

cellular amino acid biosynthetic process

1.371E-03

endoplasmic reticulum unfolded protein response

1.458E-03

cellular response to unfolded protein

1.568E-03

immune response

1.947E-03

Table 3.4: Processes relating to the Endoplasmic Reticulum are enriched in
Cluster of Up-regulated Genes. Clustering differentially expressed genes
identified a cluster of 803 continually increasing genes (Figure 3.6, cluster #2).
GO enrichment analysis of this cluster identified overrepresentation of terms
related to the endoplasmic reticulum. The table above lists the top ten GO
Processes. The “Processes” column lists the process name and the “FDR”
column lists the FDR corrected p-value that DE cluster #2 is enriched in that term
compared to a background dataset (rat genome).
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Mist1). Interestingly Mist1 null mice have a defect in acinar cell differentiation of
both the pancreas and the salivary glands [125].
Cluster #4 is enriched in lipid metabolism (Table 3.4). This cluster also contains
the transcription factor PPARg along with 19 of its known downstream effectors
including adiponectin. This expression pattern for PPARg was confirmed by
qPCR in a separate set of samples (Figure 3.7). While PPARg has been shown
to be involved in the differentiation of other cell types, most notably adipocytes, it
has never been identified in acinar cell differentiation before.
In order to identify additional expression patterns of interest, regression analysis
was used to identify clusters that significantly follow specific treads. Because this
dataset included measurements at nine time-points, complex patterns could be
identified that follow quadratic and cubic trends (Figure 3.8). 419 genes were
identified that significantly fit a quadratic trend and these genes were clustered
into eight patterns. Only eighteen genes followed a cubic pattern and were not
subsequently analyzed.
Several of the quadratic clusters were subjected to term enrichment analysis.
Cluster #6 contains many known salivary cargo proteins such as DNase I,
Chitinase, Prp15, and the immunoglobulin J chain Igj. It had been shown
previously that DNase I expression is not detected in the developing salivary
gland until the late stage of differentiation, but this adds to the list of lateregulated genes and indicates that the full repertoire of salivary components is
not established until the late-stage.
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Enrichment by GO Processes
Processes

FDR

regulation of sequestering of triglyceride

1.141E-05

acylglycerol metabolic process

6.743E-05

neutral lipid metabolic process

6.743E-05

lipid metabolic process

1.045E-04

triglyceride metabolic process

4.028E-04

glycerolipid metabolic process

5.269E-04

regulation of lipid storage

7.446E-04

triglyceride biosynthetic process

8.003E-04

glycerolipid biosynthetic process

8.003E-04

neutral lipid biosynthetic process

8.519E-04

Table 3.5: Transiently Activated Gene Cluster is enriched in Processes
Relating to Lipid Metabolism. Clustering analysis identified a cluster of
transiently up-regulated genes during differentiation (Figure 3.6, cluster #4). GO
enrichment analysis identified overrepresented terms relating to lipid metabolism.
The table above lists the top ten GO Processes. The “Processes” column lists
the process name and the “FDR” column lists the FDR corrected p-value that DE
cluster #2 is enriched in that term compared to a background dataset (rat
genome).
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Figure 3.7 PPARg is Transiently Activated during Acinar Cell
Differentiation. Cluster #4 (Figure 3.6) was shown to be enriched in genes
related to lipid metabolism (Table 3.4) and included the transcription factor
PPARg. A.) downstream targets transcriptionally regulated by PPARg that are
also in cluster #4. B.) Microarray expression pattern of PPARg confirms that this
gene is activated midway through differentiation and then returns to baseline. C.)
This expression pattern is validated by qPCR (n=3, p-value= 0.03).
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Figure 3.8 Eight Gene Expression Clusters have a Significant Quadratic
Trend. A.) Regression analysis was used to identify genes with a significant (adj.
p-value= 0.05) quadratic trend. Cluster #6 contains genes which have relatively
low expression throughout most of differentiation and then increase dramatically
starting between P9 and P15. B.) Non-standardized profiles for genes in cluster
#6 with at least a 4-fold change. This cluster contains many extracellular proteins
including many saliva components (i.e. DNase I, Chia, and Prp15).
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3.2.2 microRNA Expression
Over the last decade microRNAs have come to be recognized as important
regulators of gene expression in many processes including development and
differentiation. Little is known about their expression and potential targets in
acinar cells. To identify a potential role of microRNAs in acinar cell differentiation
we profiled their expression across differentiation. By having both mRNA and
corresponding microRNA expression patterns, potential target genes can be
identified.
As with the microarray study, LCM was used to capture acinar cells at multiple
time points across differentiation. Following the observation from the microarray
study that there are four stages during differentiation, cells were isolated at four
time points in triplicate, each representing one of the four stages (E20, P5, P15,
and P25). microRNA expression was measured by a qPCR array designed to
amplify 375 well characterized rodent microRNAs. A summary of the analysis is
shown in Table 3.6.
qRT-PCR detected 271 microRNAs repeatedly. Analysis by one-way ANOVA
identified 79 microRNAs exhibiting significant differential expression (Figure 3.9).
Subsequent t-tests between time points (Table 3.6) identified 64 microRNAs with
differential expression between the first (E20) and last (P25) time points. These
64 microRNAs encompass all significantly changing microRNAs identified by
comparing other pairs of time points. Of these, 52 microRNAs increased in
expression and 12 decreased across acinar differentiation.
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Figure 3.9 Regulated microRNA Expression during Parotid Acinar Cell
Differentiation. A.) Heatmap of differentially expressed microRNAs. Ages were
clustered based on expression pattern as in Figure 3.5. B.) microRNAs with the
largest fold change are shown. Expression is plotted in Log2.
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Comparison

Up-regulated microRNA

Down-regulated microRNA

E20 vs. P5

1

0

E20 vs. P15

14

2

E20 vs. P25

52

12

P5 vs. P15

0

0

P5 vs. P25

7

0

P15 vs. P25

0

0

Table 3.6: Summary of microRNA analysis. The number of differentially
expressed microRNAs was determined by t-test using the limma package in R,
for every possible comparison of time points.
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Clustering identifies just two major expression profiles (Figure 3.10), either
continuously increasing or continuously decreasing. There does not appear to be
any microRNAs with transient activation or repression. Table 3.7 lists the ten
microRNAs from each group with the largest fold change in expression between
the earliest time point (E20) and the latest (P25).
The microRNA with the largest fold change (miR-375) increases in expression
more than 800 fold. This microRNA is nearly undetectable by qPCR in the
embryonic stage, and progressively increases until P25 when miR-375 has the
second highest relative expression of all the microRNAs measured (it is second
only to miR-148a, aka miR-148b-2).
miR-375 is one of the few microRNAs that has been previously measured in the
adult parotid gland, and may contribute to the formation of adenocarcinoma of
the salivary gland. Down-regulation of miR-375 is often measured in tumors,
along with up-regulation of its target and proto-oncogene Plag1, a transcription
factor thought to increase unregulated cell proliferation by, at least in part,
increasing expression of Igf2 [126-128]. In order to identify whether this particular
gene is being regulated by miR-375 during cell differentiation the expression
profiles of each were used to identify a possible inverse correlation (Figure 3.11).
Like its prospective targeting microRNA, Plag1 is also significantly differentially
expressed, and is a member of cluster #1 (Figure 3.6) which is made up of
progressively decreasing genes. Plag1 expression decreases more than 6-fold
across differentiation. Log2 relative expression values were used to calculate a
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Up-Regulated microRNAs
miRname
Fold change (P25/E20)
mmu-miR-375
895.80
mmu-miR-148a
82.27
mmu-miR-145
59.62
mmu-miR-29c
25.76
mmu-let-7b
18.13
mmu-let-7c
15.07
mmu-miR-200c
15.03
mmu-miR-200a
13.55
mmu-miR-200b
10.50
mmu-miR-34a
9.91

Down-regulated microRNAs
miRname
Fold change (P25/E20)
mmu-miR-433
0.04
mmu-miR-301a
0.07
mmu-miR-434-3p
0.07
mmu-miR-503
0.09
mmu-miR-214
0.10
mmu-miR-541
0.12
mmu-miR-335-5p
0.14
mmu-miR-376b
0.17
mmu-miR-127
0.18
mmu-miR-17
0.18

Table 3.7: microRNAs with Largest Fold Change during Differentiation. Fold
change between the latest time point (P25) when the parotid gland is fully mature
and the earliest time point (E20) when the acinar cells are not terminally
differentiated was calculated for each of the differentially expressed microRNAs
(Table 3.6). The top ten up-regulated and down-regulated microRNAs are
tabulated above.
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Figure 3.10 Clustering microRNA profiles. K-means clustering was used to
group differentially expressed microRNAs into two main clusters: either
continually increasing or continually decreasing. For the above graphs,
microRNA expression was standardized to a mean =0 and standard deviation =1.
The red line traces the average pattern for the cluster, and the grey lines are
each individual observation.
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Log2 Relative
Expression

A.
Expression of miR-375 and Plag1
Across Differentiation
10.000
5.000
0.000
-5.000

E20

P5

rno-miR-375

P15

P25

Plag1

Log2 Expression
Plag1
miR-375

B.

E20
7.26
-3.32

P5
6.33
-0.08

P15
5.27
4.00

P25
4.59
6.49

correlation p-value
1
-.99
0.0002

Log2 Relative
Expression

Expression of Igf2bp2 and the let-7 Family
12.000

mmu-let-7b

10.000

mmu-let-7c

8.000

mmu-let-7f

6.000

mmu-let-7a

4.000

mmu-let-7d

2.000
0.000

mmu-let-7g
E20

P5

P15

Igf2bp2

P25

Log2 Expression
Igf2bp2
let-7a
let-7b
let-7c
let-7d
let-7f
let-7g

E20
10.50
1.84
3.95
2.08
2.02
2.89
3.40

P5
8.64
2.68
5.50
3.44
2.32
3.31
4.21

P15
6.90
3.97
7.58
5.13
3.35
4.00
4.63

P25
6.28
4.60
8.13
5.99
3.64
4.76
6.21
75

correlation
1
-0.99
-0.99
-0.99
-0.97
-0.95
-0.90

p-value
0.01
0.003
0.006
0.03
0.047
0.1

Figure 3.11: MicroRNA Expression is Significantly Inversely Correlated with
Known Target Genes. A.) Log2 expression of Plag1 and mir-375 from
microarray and qPCR measurements respectively is plotted in the top panel.
Expression data is tabulated in the bottom panel along with the Pearson
correlation coefficient and p-value. B.) Log2 expression is plotted for Igf2bp2 and
six members of the let-7 family of microRNAs in the top panel. In the bottom
panel expression is tabulated along with the Pearson correlation coefficient
between each microRNA and Igf2bp2 and p-value.
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Pearson's correlation coefficient, and a t-test used to evaluate significance. This
analysis identified a significant inverse correlation (r = -0.9998, p-value = 0.0002)
indicating that Plag1 is likely a target of miR-375 and that its expression is being
progressively down-regulated by this microRNA during differentiation.
Other microRNAs of interest include members of the let-7 family which are
known to regulate the cell cycle. There are ten members of this highly conserved
family in the genomes of humans and mice [129], and six of them are upregulated during acinar cell differentiation (Figure 3.11). Their change in
expression ranges from 3-fold (let-7d) to more than 18-fold (let-7b).
Differentiation and cell cycle progression are often thought of as having opposing
roles in the cells. It has often been observed that exiting the cell cycle will
stimulate terminal differentiation, while activating the cell cycle is an inhibitor of
differentiation [130]. Known direct targets of the let-7 family include Igf2bp2, an
mRNA binding protein which is known to enhance the translation of many genes
including several oncogenes and activators of proliferation, Igf2, and c-myc [131].
Igf2bp2 decreases significantly across differentiation and its expression profile is
inversely correlated significantly with five of the let-7 genes (Figure 3.11).
Several members of the miR-200 family are also significantly up-regulated during
differentiation. Previous work identified miR-200c as up-regulated in the end
buds (the region of future acinar cell differentiation) during SMG branching
morphogenesis. This microRNA was found to have anti-proliferative effects by
regulating FGFR signaling through targeting of Vldlr [111]. In our dataset three
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members of the miR-200 family (miR-200a, miR-200b, and miR-200c) are
significantly upregulated (Figure 3.12). However, its direct target gene, Vldlr, is
not differentially expressed, indicating that these microRNAs are acting on a
different target during the later stages of gland development.
3.3 Discussion
For the first time, acinar cell specific gene expression was profiled across
terminal differentiation in vivo by selectively isolating acinar cells at multiple time
points starting with immature pro-acinar cells in the late embryo (E18), and
ending with fully mature acinar cells at P25. By using a combination of microarray
hybridization and qPCR, expression of > 30,000 expression probes and 375
microRNAs were measured at nine time points in triplicate leading to the
identification of > 800,000 gene expression measurements during differentiation
which represents a large portion of the transcriptome.
Analysis of these measurements led to the identification of individual differentially
expressed genes. More than 2500 mRNAs change expression, and were used to
cluster the ages into four stages: an embryonic stage (E18, E20, and P0), early
postnatal stage (P2, and P5), mid postnatal stage (P9 and P15), and a late stage
(P20 and P25). Gene expression changes relatively little between members of
the same stage, while large changes are seen between members of different
stages.
In order to identify the processes involved in differentiation, the gene expression
profiles were clustered and used for gene ontology enrichment analysis. Of
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Expression of the miR-200 Family and
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rno-miR-200b
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miR-200c
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3.01
3.83
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P15
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4.62
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5.51
7.02
5.56

correlation p-value
1
0.69
0.51
0.64
0.56
0.69
0.51

Figure 3.12: Vldlr Expression is not Inversely Correlated with the miR-200
Family. Log2 expression is plotted for Vldlr and three members of the miR-200
family of microRNAs in the top panel. In the bottom panel expression is tabulated
along with the Pearson correlation coefficient between each microRNA and Vldlr
and p-value. None of the correlation coefficients are significant indicating that
Vldlr is probably not a target of the miR-200 family during differentiation.
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particular interest is a large cluster of increasing gene expression that contains
many known parotid gland terminal differentiation markers including cargo
protein and components of the regulated secretory pathway (i.e. amylase, PSP,
Rab3d). GO enrichment identifies ER signaling as an enriched process.
Regulation of this cluster is likely to be important for the development of the fully
differentiated phenotype, and understanding the components involved in this
cluster is vital to understanding how differentiation is controlled. Enrichment
analysis using transcription factor targets identified both Mist1 and Xbp1 targets
as over-represented, indicating that these two transcription factors could be
important regulators of differentiation.
Xbp1 is most known as part of the Unfolded Protein Response (UPR). It is
activated in response to ER stress, and binds to Unfolded Protein Response
Elements (UPREs) or ER stress elements (ERSE I/II) as a dimer with Atf6 where
it up-regulates gene expression. Many of the targets include ER chaperones and
members of the ER associated degradation system (ERAD), highlighting its role
in ER homeostasis, but there are many other processes it is thought to be a part
of. Recently, the role of Xbp1 has expanded to include development and
differentiation particularly in cells with a high protein folding burden (i.e. acinar
cells, plasma cells, muscle cells). It is involved in the biogenesis and expansion
of the ER and Golgi in these cells leading to higher protein production and
secretion. Xbp1 is necessary for differentiation of plasma cells from B cells, and
Xbp1 -/- mice show disruptions in both salivary gland and exocrine pancreas
development [132]. Pancreatic acinar cells show reduced expression of zymogen
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granules and associated cargo proteins (i.e. amylase, elastase) at the mRNA
level, suggesting disruptions in differentiation. Xbp1 is also required for
homeostasis of pancreatic acinar cells [133].
Our results show that Xbp1 activity is enriched in a gene expression cluster
containing many lineage specific and terminal differentiation associated genes.
These genes increase in expression across differentiation and are likely
important for the cells to attain the fully differentiated phenotype. Because we
identified Xbp1 as a major regulator in this cluster, its activity is probably
necessary for proper mRNA expression, and terminal differentiation.
Mist1 (aka Bhlha15) is the other enriched transcription factor identified in cluster
#2 (Figure 3.6). This gene is considered specific to acinar cells, and is reported
to be directly downstream of Xbp1. Mist1 -/- mice have disruptions in salivary and
pancreatic acinar cell morphology. These cells contain few granules, and lack a
polarized cytoplasm (the nucleus is no longer basally located).
In a completely novel observation, Pparg controls the expression of a transient
gene cluster. The transcription factor Pparg and 19 of its downstream targets
increases in expression shortly after birth, peaks around postnatal day 5, and
decreases back to basal levels by the time the gland is fully mature. The Pparg
targets include many genes which have not been identified in salivary gland
development before, but at least one has been shown to affect the physiology of
the adult gland. In our dataset, the hormone adiponectin is produced downstream
of Pparg (Figure 3.7). Expression of this protein is mostly associated with
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adipose tissue where it is released and acts on other tissue through its receptors
(Adipor1 and Adipor2). It has been shown that these receptors are present on
acinar cells of the submandibular gland, and adiponectin can increase salivary
flow [134]. Our microarray data shows that both adiponectin receptors are
expressed throughout differentiation in the parotid (data not shown), and so
adiponectin could be acting as an autocrine factor to stimulate secretion for a
short period of time postnatally.
This analysis also identified novel microRNA expression changes. This is the first
study to measure microRNA expression in the salivary gland during
differentiation. 52 microRNAs showed a net increase in expression while 12 had
a net decrease. miR-375 had the largest fold-change measured: its expression
increased more than 800-fold between embryonic day 18 and postnatal day 25. It
showed extremely low expression in the embryo and was undetectable by qPCR
in some of these samples suggesting it does not play a role in early gland
development, only differentiation. It is likely targeting Plag1 which shows inverse
expression in our data. This interaction has been reported in salivary gland
cancer where decreased miR-375 leads to increased expression of the
oncogenic Plag1 [126], but this is the first report of this interaction in
differentiation. Like many oncogenes, Plag1 could also be playing a role in
development. For instance, it has been reported to increase proliferation in
culture and in tumors through up-regulation of its target gene, the mitogenic IgfII
[128, 135]. Interestingly, in a Plag1 -/- model, small organ size was reported but
without the expected decrease in IgfII expression indicating this transcription
82

factor is controlling growth through multiple pathways [136]. In the salivary gland,
high Plag1 expression in the embryo could be contributing to growth and cellular
expansion. miR-375 then would be necessary during later development when
cells are exiting the cell cycle and becoming fully differentiated. Many mitogenic
factors inhibit differentiation, and so increased miR-375 expression could be
promoting differentiation in parotid acinar cells.
A miR-375 knockout mouse line exists [137], but a phenotype relating to the
salivary glands has not been investigated. A possible future direction would be to
measure acinar cell differentiation by measuring the expression level of salivary
acinar cell markers such as amylase and PSP in the knockout versus the
wildtype.
The let-7 family of microRNAs could also be influencing proliferation. Six of the
let-7 microRNAs increase in expression during differentiation (Figure 3.11) and
five are significantly inversely correlated with Igf2bp2, a canonical target of let-7.
Igf2bp2 expression decreases 18-fold during differentiation. Interestingly, like the
miR-375 target Plag1, Ig2bp2 plays a role in regulating Igf2 expression. Where
Plag1 increases transcription of Igf2, Igf2bp2 is an RNA binding protein which
has been shown to stabilize Igf2 mRNA and promote translation [138]. Both miR375 and let-7 could be working together to down-regulate Igf2 signaling during
differentiation, which is associated with growth and proliferation.
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CHAPTER 4: A GENE REGULATORY NETWORK DRIVING EXPRESSION OF
TERMINAL DIFFERENTIATION GENES
4.1 Introduction
Terminal differentiation involves sustained changes in gene expression patterns
as progenitor cells mature and take on the fully differentiated phenotype. These
changes lead to the directed expression of proteins which are markers of
terminal differentiation. In the case of salivary acinar cells, this means that cells
acquire expression of secreted cargo proteins as well as all the molecular
machinery needed for large scale production and regulated secretion of these
proteins into saliva [78]. This specialized differentiation is required for proper
saliva production and loss of these cells results in poor oral health and quality of
life due to chronic xerostomia which is a common complaint in the general
population [30, 32], and is currently difficult to treat. The best treatment option for
patients would be one that addressed the underlying cause of xerostomia in
many people: acinar cell atrophy [57]. Once destroyed by radiation or
autoimmune disease, these cells typically do not grow back by themselves.
Understanding the regulation of gene expression changes during differentiation
could aid in efforts to regenerate fully differentiated cells from more naïve
progenitors or stem cells. Also, transcription factors needed to drive expression
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changes during differentiation could be necessary to maintain homeostasis in the
adult gland, and these factors could be used to maintain differentiated cells in
culture which could be used for the construction of artificial glands.
In the previous section the global changes in mRNA and microRNA expression
were measured across acinar cell differentiation. Transcriptional regulators
controlling the terminal differentiation phenotype would presumably be
upregulated during this process, and would be captured as differentially
expressed genes in our analysis. Also the comparison of microRNA expression
profiles with mRNA expression would identify microRNA:mRNA interactions
during differentiation. This differential expression data could then be used to
identify possible gene regulatory networks driving differentiation.
MicroRNA expression is now being considered in the context of multiple
interactions as well as indirect effects, and perturbation of their expression has
been predicted to impact whole gene networks. This current understanding has
led to several models of how these small RNAs could be impacting gene
networks these include feed-back loops with transcription factor targets, or
stabilizing gene expression in order to increase robustness in the face of outside
perturbation. In this context microRNA expression changes during differentiation
could be effecting entire networks down-stream.
For this analysis we used a knowledge-based approach along with our
expression measurements to predict transcript regulatory interactions driving the
expression of several terminal differentiation genes. We also integrated our
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expression data with in silico based predictions to identify novel
microRNA:mRNA interactions.
This analysis identified an entirely novel tripartite gene regulatory network driving
the expression of the terminal differentiation markers PSP, Rab3d, Rab26, and
Connexin32. In one arm of the network, pro-stem cell transcription factors
decrease across differentiation, a genetic switch activates Xbp1 expression by
inhibiting the repressor Pax5, and a pro-differentiation arm activates expression
of terminal differentiation genes.
This network also includes several novel microRNA:TF-mRNA interactions. Prostem cell TF Klf4 is targeted by miR-200c, and miR-29c. Sox11, another TF
involved in stem cell maintenance, is targeted by miR-200a, and miR-30a, and in
vitro testing of these interactions suggests that these microRNAs are acting
cooperatively to decrease expression.
4.2 Results
4.2.1 Knowledge-based Predictions: Regulators of PSP and Amylase
Little is known about the transcriptional regulation of acinar cell lineage-specific
genes during terminal differentiation. As we and others have noted, salivary
specific cargo proteins such as amylase, PSP, and DNase I are dramatically
upregulated during postnatal differentiation [139], but little information has been
available regarding the expression of transcription factors which could be
necessary for promoter activation. PSP in particular is essentially parotid-
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specific, and is one of the most abundant proteins in saliva [140, 141]. In our
approach, we measured a large portion of the transcriptome across
differentiation, and identified >2500 differentially expressed genes (Figure 3.5),
many of which had not been described in parotid development before, including
>500 transcription factors (Figure 4.1).
A knowledge-based approach, which uses interactions curated from
comprehensive literature searches, was used to predict transcription factors
upstream of salivary-specific cargo proteins. Our transcriptome data could then
be incorporated to identify differentially expressed transcription factors with
expression patterns that correlated with the predicted target gene, indicating a
possible interaction with the gene promoter. These genes (e.g. amylase, PSP)
were uploaded as seed nodes for network analysis. A network is expanded
around a seed node according to selected filters and criteria. Because our data
consisted of changes in mRNA expression, edges (interactions between genes)
were filtered for transcription regulatory interactions up-stream of the selected
seed node. This results in the addition of mostly transcription factors that have at
least one literature source supporting direct regulation of the target of interest.
Using this algorithm, up-stream regulators of the amylase enzyme were predicted
(Figure 4.2). There are two amylase genes up-regulated during parotid
development, Amys (salivary), and Amyp (pancreatic). Up-stream from these
genes there are six predicted regulatory transcription factors. Only one is
predicted to activate transcription (Gata6), as indicated by a green arrow, and for
the others the direction of regulation is unknown (grey arrow). None of these
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Figure 4.1 Hundreds of Transcription Factors are regulated during Acinar
Cell Differentiation. A Heatmap was generated as is Figure 3.5. Using the
expression data for 550 transcription factors that were identified in the dataset of 2656
differentially expressed genes (Table 3.1).
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Figure 4.2: mRNA Expression of Knowledge-based Amylase Regulators
does not Change during Differentiation: The knowledge-based network
analysis software Metacore was used to build a prospective gene regulatory
network using the enzyme, and parotid terminal differentiation marker amylase
as a seed node. Edges (depicted as arrows) were incorporated by the algorithm
based on a comprehensive literature search for up-stream transcription
regulators. A green arrow indicates an activating interaction while grey arrows
indicate that the direction of interaction is unknown. A circle next to the gene icon
indicates that it is significantly differentially expressed as measured by
microarray (Figure 3.7). A red circle indicates that net expression increases while
a blue circle means expression decreases. Of all the genes in the generated
network, only the two amylase genes are differentially expressed.
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transcription factors is differentially regulated at the mRNA level. Parotid
secretory protein (PSP) is a highly expressed parotid-specific terminal
differentiation marker. Three transcription factors are predicted up-stream (Figure
4.3), two of which are up-regulated during differentiation: Elf5 and Ese3. Elf5
expression increases modestly, 1.6-fold, during differentiation, and Ese3
expression increases 3.6-fold. Elf5 is predicted to activate PSP expression
(green arrow) while the direction of Ese3 regulation is not known (grey arrow). In
order to expand the network to incorporate other potential regulators, Elf5 was
used as a seed node with the same filters applied. Stat5a, which is up-regulated,
is predicted to up-regulate Elf5 expression. This two-step network predicts PSP
regulation through Stat5a and Elf5. Possible microRNA regulation was also
investigated, but none of the network genes were predicted targets (based on in
silico predictions; Targetscan) of any differentially expressed microRNAs.
4.2.2 Novel Regulator of PSP Expression
Because both Elf5 and Ese3 expression increases modestly compared to PSP
expression we hypothesized the existence of novel regulators during
differentiation. Also, because this is the first large scale expression study of
salivary acinar cell differentiation, there are probably novel cell type specific
interactions which would not be identified by a knowledge-based approach. In
order to identify new transcription factor interactions, the salivary specific region
of the PSP promoter was surveyed for predicted consensus sequences. Two
Xbp1 binding sites (CCACG) were identified close to the transcription start site
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Figure 4.3: Elf5 is a Possible Regulator of PSP during Differentiation.
Network shows knowledge-based algorithm predictions of upstream transcription
regulators of the parotid secretory protein (PSP, aka Bpifa2). ELF5 is a
transcription factor commonly expressed in glandular epithelia, and it is
significantly up-regulated across differentiation (Log2 fold change 0.68 between
E18 and P25). It is predicted to activate PSP expression (green arrow). No
differentially expressed microRNAs targets members of the network.
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(-31nt to -35nt, and -44nt to -48nt). Xbp1 expression increases 6.5 fold over the
course of terminal differentiation, along with many of its known down-stream
effectors. Its targets are significantly enriched in DE cluster #2 (Figure 3.6).
Together, this indicates that Xbp1 transcriptional activity is also increasing over
this time span.
Luciferase reporters were constructed containing either 500bp or 1000bp of the
PSP promoter immediately up-stream of a luciferase gene. Both versions of the
promoter showed strong dose dependent induction following co-transfection with
an Xbp1 expression vector in ParC5 cells (Figure 4.4). This indicates that Xbp1
could be part of a new transcription regulatory network activating PSP expression
during terminal differentiation.
4.2.3 Transcription Regulatory Network Driving PSP Expression through Xbp1
To investigate a possible network, Xbp1 was included with PSP as seed nodes
for network analysis, and an interaction between the two genes was added.
Using the filtered algorithm, multiple steps of predicted edges were evaluated
sequentially up-stream and down-stream of Xbp1 for those with expression
changes correlating with the proposed interaction which were then incorporated
into the network (Figure 4.5). This led to the identification of multiple steps of
transcription regulatory interactions which lead to the expression of acinar cell
specific genes. In the network diagram, the terminal differentiation genes are
shown at the bottom with each up-stream step acting from above. In the context
of this time course experiment, expression changes at the top of the network
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Figure 4.4: Transcription Factor Xbp1 Activates the PSP Promoter: A.) The
PSP promoter contains two consensus binding sites for Xbp1 (the CCACG box)
just up-stream of the TSS. B.) The PSP promoter was cloned up-stream of a
luciferase reporter, and co-transfected into ParC5 cells with an expression vector
containing the spliced isoform of Xbp1 (Xbp1-s). Expression was normalized to a
renilla control. Xbp1-s activated expression from both the 1kb and 500bp region
of the PSP promoter (n=3).
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Figure 4.5 Transcription Factor Network. A knowledge-based algorithm was
used to add transcription regulatory interactions up-stream and down-stream of
Xbp1. Nodes were added if they were differentially expressed (Figure 3.5), and if
their expression profile was consistent with the predicted interactions. A green
arrow indicates an activating interaction and a red line indicates an inhibiting
interaction.
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would be required early in differentiation with each subsequent level occurring as
time proceeds to drive the network forward to the lineage specific phenotype. In
order to develop a comprehensive network from our data, microRNAs were next
included based on predicted targeting of network transcription factors. By having
expression data for both mRNAs and microRNAs context specific interactions
can be predicted. In silico predictions alone (based on sequence
complementarity and conservation) often lead to the identification of hundreds of
potential targets per microRNA. Many of these genes may not even be
expressed in the system under study, or multiple targets expressed each with
different (and unknown) affinities for the microRNA leading to competitive
binding, the results of which could only be resolved by measuring gene
expression under conditions of microRNA perturbation. There are also several
pseudogenes that have been identified which contain microRNA binding sites,
and have been reported to act as sponges, sequestering microRNAs, and
inhibiting them from binding protein coding genes. By having expression data,
true interactions during differentiation can be identified from sequence based
predictions.
The prediction algorithm Targetscan [142] was used to identify microRNA targets
for the 64 differentially expressed microRNAs (Figure 3.9), leading to the
identification of 5184 potential target sites in 851 unique mRNAs. Importantly,
these genes are significantly enriched in DE cluster #1, and deficient in DE
cluster #2 (Figure 3.6) (Fisher's exact test p-value < 0.05) Table 4.1 indicating
that microRNAs may have an important impact on overall gene expression trends
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Targets of DE microRNAs are
over represented in cluster #1 and under represented in cluster
#2
DE cluster (Figure
3.6)
odds.ratio p.value.greater p.value.less
0.01
clust1
1.21
0.99
0.02
clust2
0.83
0.99
clust3
0.00
1.00
0.33
clust4
0.73
0.94
0.09
clust5
0.68
0.85
0.29
clust6
1.21
0.34
0.77
clust7
1.47
0.09
0.95
clust8
0.45
0.89
0.39

Table 4.1: microRNA Target Genes in Enriched in Cluster of Up-regulated
Genes during Differentiation. Using Targetscan, target genes were predicted
for each differentially expressed (DE) microRNA. A Fisher's exact test was used
to test for over or under representation of a gene cluster (Figure 3.6) in the list of
predicted targets. There are three data columns. Odds.ratio: odds of drawing a
gene from that cluster in the list of interest (predicted targets) compared to a
background list (rat genome), p.value.greater: probability that the genes in that
cluster are over represented in the list of interest, p.value.less: probability that the
genes in that cluster are underrepresented in the list of interest.
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during differentiation. Of the genes in DE cluster #1 (which have progressively
decreasing expression), 32% are predicted to be direct targets of microRNAs that
are part of DE cluster #2 (progressively increasing).
microRNA target predictions were then filtered for only those interactions that
involved genes in the regulatory network, and microRNAs were incorporated into
the network if their expression profile was inversely correlated with the predicted
target mRNA (Figure 4.6). This lead to the identification of eight
microRNA:mRNA interactions involving seven microRNAs and four genes.
The hypothetical network (Figure 4.6) suggests that expression of Egr1 early in
development maintains expression of Klf4 [143]. Similarly to the parotid, Egr1 is
highly expressed in hematopoietic stem cells and decreases on differentiation
[144]. Klf4 is involved in stem cell maintenance and inhibits terminal
differentiation [145]. As development proceeds, the observed increases of miR29c, miR-375, miR-148, and miR-200c may drive the observed decreased
expression of Klf4 mRNA. Sox11 is initially strongly expressed, and is an
activator of the Pax5 gene, which is an inhibitor of Xbp1 transcription factor gene
expression [146]. Increasing expression of miR-200a and miR-30a may combine
to repress expression of Sox11, thereby decreasing stimulation of Pax5. Prdm1
(Blimp1) mRNA increases transiently during mid-differentiation, which may inhibit
Pax5. The Prdm1-Pax5-Xbp1 genes are reported to form a genetic switch which
regulates the timing of differentiation of antibody secreting plasma
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Figure 4.6: Gene Regulatory Network Driving Expression of Terminal
Differentiation Genes. Network containing predicted edges from both
knowledge-based resources and in silico based predictions of microRNA:mRNA
interactions. Edges connecting nodes are either a green arrow indicating
activation or a red line indicating repression. A small graph next to each node
plots the relative expression for that gene across differentiation. The network is
divided into three main arms, a stemness arm on the right, a genetic switch in the
middle, and a differentiation arm of the left where transcription factors such as
Xbp1 and Mist1 drive expression of differentiation markers such as PSP.
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B cells [147, 148]. This genetic switch has not previously been seen in parotid
differentiation, and may contribute to the observed increase of Xbp1 mRNA.
The observed decrease of miR-214 which may target Xbp1 mRNA, combined
with the positive feedback loop between Xbp1 and Atf6 alpha [149, 150], would
help maintain the observed elevated expression of Xbp1. Down-stream of Xbp1,
along with PSP, is Mist1 (Bhlha15). Xbp1 is known to regulate the expression of
transcription factor Mist1. This basic helix-loop-helix family member is highly
expressed in serous acinar cells as well as other protein secreting cells, such as
plasma cells. Mist1 is considered necessary for plasma cell differentiation, and in
knockouts acinar cell maturation is impaired during development leading to
disorganized cells that lack cytoplasmic and plasma membrane polarity, and
contain far fewer secretory granules [125, 151, 152]. Among Mist1 target genes
are Rab3d and Rab26 which are necessary for secretory vesicle maturation. All
three of these genes (Mist1, Rab3d, and Rab26) significantly increase (at the
mRNA level) during differentiation.
4.2.4 Testing Transcription Factor and MicroRNA Interactions
Several of the proposed regulatory interactions (edges) of this network were
directly tested by transfection experiments. According to the network, Xbp1 is
directly up-stream of Mist1 (Bhlha15) [153] [132]. Mist1 and Xbp1 in vivo
expression increases 21-fold and 6.5-fold respectively between the earliest and
latest time points (Figure 4.7). Their expression pattern was significantly
correlated across the time points measured
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Figure 4.7: Xbp1 regulates Mist1 Expression. A.) Both Xbp1 and Mist1
increase expression significantly during acinar cell differentiation. B.) Mist1 and
Xbp1 expression is significantly correlated. C.) The Mist1 promoter was cloned in
front of a luciferase vector and co-transfected in ParC5 cells with an expression
vector containing the spliced version of Xbp1 (Xbp1-s). Activity significantly
increased with increasing concentration of Xbp1-s (n=3).
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(correlation coefficient= 0.97, p-value= 1.4*10-5) (Figure 4.7). Transfections of a
Mist1 promoter (-500 - +15) luciferase construct into immortalized rat parotid
acinar cells (ParC5 cell line) confirmed direct activation of the Mist1 promoter by
the spliced (activated) form of Xbp1 (Figure 4.7). This experimentally supports
the predicted interaction in this network. Possible regulation of the Psp gene by
the Mist1 transcription factor was also investigated. This interaction was not
predicted by a knowledge-based algorithm, but to further identify novel
interactions with terminal differentiation markers, a region of the PSP gene
containing two E-box sites was cloned into a luciferase reported in order to test
activation. These two consensus sequence sites are not in the promoter region.
Though the promoter is the most common binding site, transcription factors have
also been shown to regulate gene expression through binding sites within
introns. Co-transfection of Mist1 cDNA did not lead to activation of the Psp 500
bp promoter alone(not shown), nor did it activate a 1.5 kb Psp promoter
construct even in the presence of the Mist1 dimerization partner Tcf3/E2A [154]
(Figure 4.8). The E-box regions flank exon three in the PSP gene, and this
promoter+intron/exon construct was significantly activated 2.3-fold by cotransfection with Mist1 and Tcf3 cDNAs (p=0.0227), whereas the 1.5 kb Psp
promoter was not activated (Figure 4.8). Neither Tcf3 nor Mist1 alone
significantly activated the Psp reporter construct (not shown). Tcf3 was included
in these experiments as a heterodimerization partner with Mist1. Since Tcf3
mRNA was not differentially expressed (p=0.25), it is not included in the
proposed regulatory network, however, it is constitutively expressed throughout
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Figure 4.8: Mist1 and Tcf3 Activate PSP Expression from the Introns. A.)
The promoter region of PSP does not contain a Mist1 consensus sequence,
however, there are two E-box sites in the introns flanking exon 3.B.) Two regions
of the PSP gene were cloned up-stream of a luciferase reporter. In the first clone,
only 1.5kb of the promoter was used (PSP 1.5kb promoter), and in the second,
regions of the PSP gene containing the introns of interest were included (PSP
1.5kb promoter + introns). These clones were co-transfected with expression
vectors containing Mist1 and Tcf3. These transcription factors activated
expression only in the clone containing the introns (n=4, p-value = 0.26).
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acinar cell differentiation. While Tcf3 is typically present in most cell types, it
apparently has inadequate levels in the ParC5 cells used for transfections.
Overall, these experiments indicate that the increase of Mist1 expression during
acinar differentiation contributes to the increase of Psp gene expression through
binding sites flanking exon 3. Several microRNA:mRNA interactions were also
tested using a luciferase reporter. Four microRNAs, which increased expression
late in differentiation, are predicted to target Klf4 mRNA. Figure 4.9 shows the
Log2 relative expression of miR-29c during acinar differentiation compared to
that of Klf4 mRNA. Klf4 does not decrease in expression until stage 3 in
postnatal development when miR-29c increases. Expression of these two genes
are negatively correlated across acinar differentiation (Pearson’s r= -0.79; p =
0.011). In order to test potential microRNA target genes, cells were cotransfected with a microRNA mimic and a luciferase expressing plasmid
containing a 3'UTR of interest. Transfection experiments confirmed repression of
rat Klf4 by miR-29c (Figure 4.9). Several other microRNAs are predicted to target
Klf4, among them miR-200c, which has relatively low expression in the embryo
and early postnatal gland but significantly increased in expression by P15. It has
been shown that Klf4 is targeted by miR-200c [155, 156], and luciferase assays
confirmed this interaction in a parotid cell line (Figure 4.9).
Xbp1 mRNA increased expression 6.5-fold across differentiation, while its
targeting miR-214 decreased more than 10-fold (Figure 4.9). Xbp1 3'UTR
contains a known miR-214 binding site in humans [157]. Although this sequence
is not conserved in rats, the rat 3'UTR contains an alternate miR-214 predicted
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Figure 4.9: Several microRNAs Target Transcription Factors in the Network.
A.) log2 expression is plotted for five of the network microRNAs (Mir-214, miR200c, miR-29c, miR-200a, and miR-30a) and their corresponding predicted target
(Xbp1, Klf4, and Sox11) respectively. Each of the microRNA:mRNA pairs is
inversely correlated. B.) Each of the 3’UTRs containing the microRNA target was
cloned downstream of a luciferase reporter, and was co-transfected in ParC5
cells with a microRNA mimic. Expression was normalized to renilla and to an
empty (no 3’UTR) luciferase vector as in Jacobs et. al. [123]. Neither miR-200a
nor miR-30a alone down-regulated expression from the Sox11 3’UTR but
expression was inhibited when both were transfected together (n=3 for miR-29c,
miR-200a, miR-200c, and miR-200a/30a) (n=4 for miR-30a and miR-214) (p =
0.014, 0.012, 0.025, 0.28, 0.23, and 0.017 respectively).
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binding site, which was cloned into a reporter, and co-transfection experiments
demonstrate repression of rat Xbp1 by miR-214 (Figure 4.9).
Sox11 expression decreased significantly after birth, and it is predicted to be
targeted by several differentially expressed microRNAs. Assays with miR-200a,
and miR-30a did not show any repression of the reporter, however, a construct
containing binding sites for both miR-200a and miR-30a was repressed when cotransfected with both microRNAs (Figure 4.9), indicating that these microRNAs
are acting cooperatively to repress expression. Taken together, these microRNA
transfection experiments provide experimental support for five of the edges in the
proposed network.
4.3 Discussion
In this section expression measurements spanning nine time-points during acinar
cell differentiation were integrated into gene regulatory networks containing both
transcription factors and microRNAs. These networks were used to identify
factors important for the regulation of terminal differentiation markers.
Our knowledge-based approach identified several transcription factors regulating
the cargo protein gene PSP. Both Elf5 and Ese3 have been reported to activate
the PSP promoter [158], but our data shows their expression changes are
modest in the mature acinar cells compared to the embryo.
In order to identify major regulators of PSP, we predicted and validated several
novel interactions activating the PSP promoter. Both Xbp1 and Mist1 activate
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PSP expression, and, as shown in the last chapter, these two transcription
factors increase significantly during differentiation.
Using these novel and knowledge-based transcription interactions along with in
silico based microRNA target predictions, gene regulatory interactions driving
expression of terminal differentiation genes were predicted. When expression covariance supported the interaction, it was included in a network, leading to the
identification of a gene regulatory network which drives the expression of several
differentiation markers such as PSP, connexin32, Rab3d, and Rab26 (Figure
4.6).
This putative network provides a context for changes in transcription factors
which regulate differentiation. The network identifies two main branches; initial
expression of stemness factors (Sox11, Klf4, and EGR1, none of which have
been describe before in parotid differentiation) which inhibit differentiation, and
subsequent switch to an Xbp1 pathway which drives and maintains markers of
terminal differentiation. Our network suggests that Klf4 is initially stimulated by
Egr1 and, remarkably, subsequently repressed by 4 different microRNAs which
increase strongly in the late stages. We demonstrate that either miR-200c or
miR-29c can down-regulate the expression of Klf4. By affecting its expression,
these microRNAs could be important drivers of terminal differentiation. This is
one example of the broad observation that microRNAs have extensive roles
driving parotid differentiation.
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Sox11 expression was elevated in embryonic stage acinar cells, decreasing
dramatically immediately after birth apparently due to concerted action by both
miR-200a and miR-30a. Sox11 is important in neurogenesis and involved in stem
cell survival [58], and its down-stream factor, Tead2, is involved in maintaining
ES cell identity and inhibiting differentiation [159]. In our mRNA profiles, Tead2
directly parallels Sox11 expression across parotid differentiation. Hence,
repressing Sox11 promotes differentiation and also diminishes a stemness
program. Sox11 directly activates transcription of the Pax5 gene [146]. Sox11 is
not expressed in normal lymphoid progenitor cells, however, in mantle cell
lymphoma tumors it activates Pax5 thereby blocking differentiation [146]. While
Pax5 probes were not present in the microarray used in the current experiments,
we infer that its expression decreases downstream of Sox11 expression
changes. Pax5 is a transcriptional inhibitor of Xbp1, and decreasing its
expression would contribute to Xbp1 activation. The Prdm1-Pax5-Xbp1 genetic
switch is well characterized in differentiating immune plasma cells [147, 148], and
we suggest is active in parotid acinar cells, with the additional regulation by
Sox11.
Parotid acinar expression of Xbp1 is apparently maintained low in the embryo by
dual repression entailing both direct repression by miR-214, and indirectly by
Sox11 activating the Pax5 repressor.
Downstream of Xbp1, the serous exocrine specific transcription factor Mist1 is
up-regulated. We confirm direct regulation of the Mist1 promoter by Xbp1 in a
parotid cell line (Figure 4.7). Xbp1 and Mist1 likely work as 'scaling' factors, a
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concept developed by Mills et. al. [160] which contributes to quantitative
differentiation.
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CHAPTER 5: GENE REGULATORY NETWORK AND DIFFERENTIATION IN
VITRO
5.1 Introduction
In the previous section single edges of a gene regulatory network were validated
in vitro. In this section multiple successive interactions (edges) will be tested in a
cell culture model of parotid acinar cells.
The ParC5 cell line was derived from rat parotid acinar cells [63], and have since
lost expression of many terminal differentiation genes (Figure 5.1). This ability to
spontaneously de-differentiate in culture has made acinar cells difficult to
maintain. The ability to drive differentiation in culture would be beneficial towards
the goal of maintaining the acinar cell phenotype in culture and using these cells
to construct artificial glands.
Work with the similar cell line ParC10 has shown increased differentiation when
cultured on matrigel. The 3D spheres that form express polarized tight junction
(TJ) proteins, and increased expression of aquaporin5 (Aqpr5). However this
does not translate into other three dimensional culture matrices such as fibrin
hydrogels, which have been used in the formation of artificial organs (because
matrigel is tumorigenic it cannot be used for this purpose). The ability of
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transcription factors to drive differentiation in these cells has not been
investigated.
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Figure 5.1: ParC5 Cells are No Longer Terminally Differentiated. Gene
expression was compared between ParC5 cells and an adult parotid gland (rat)
by qPCR. Expression was normalized to Gapdh. Relative expression is plotted in
a log10 scale. Both Amylase and PSP are reduced more than 100,000-fold and
Mist1 more that 10,000-fold while the ubiquitous transcription factor Tcf12
remains unchanged.

111

The gene regulatory network from the previous section includes transcription
regulatory interactions that drive the expression of terminal differentiation genes.
The TF Xbp1 and Mist1 seem to be especially involved in acinar cell specific
expression in vivo, and this section addresses the hypothesis that they can also
drive expression in vitro.
A method for activating Atf6 and Xbp1 was investigated in ParC5 cells. Both are
activated as part of the unfolded protein response (UPR). Atf6 protein is cleaved
into an active form which can then up-regulate transcription. Xbp1 has a unique
mechanism of activation. It is actually ubiquitously transcribed in cells and is
translated into a weakly activating transcription factor. However, when the
endoribonuclease Ire1 is activated in response to ER stress, 26nt of Xbp1 mRNA
is spliced out in the cytoplasm leading to the translation of a highly active
transcription factor. In our study we used the ER stress agonist tunicamycin to
induce splicing of endogenous Xbp1and activation of Atf6 in all cells which
should lead to a robust response (Figure 5.2).
Measurements of down-stream effectors showed that Xbp1 can robustly induce
expression of Mist1. Other genes further down-stream in the network such as
PSP, Connexin32, and Rab3d are not induced upon Xbp1 activation suggesting
there are additional unknown factors, possibly epigenetic, that are regulating
transcription of differentiation genes.
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Figure 5.2: Tunicamycin Treatment will Activate Endogenous Transcription
Factors in the Differentiation Arm of the Network: Tunicamycin is an activator
of the unfolded protein response. It will activate the transcriptional activity of Atf6
to increase Xbp1 expression and the RNase activity of IreI which will cleave
Xbp1 mRNA into the active form. Based on our network model (Figure 4.6) this
will increase the expression of differentiation markers down-stream.
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5.2 Results
5.2.1 Tunicamycin Treatments
ParC5 cells were maintained in supplemented DMEM/F12 media as described by
Quissell et. al. [63]. After 8 hours of 1 ug/ml tunicamycin treatment (or DMSO for
controls), cells were allowed to recover overnight (~ 16 hours) before RNA was
extracted and gene expression was measured by qPCR. The 2^-ΔΔCT method was
used to calculate normalized relative gene expression [124]. Rplp2 was used for
normalization as its expression was found to be the most stable of a selected
panel of housekeeping genes. Differential expression was evaluated using a ttest with a p-value < 0.05 considered significant.
Both Xbp1 and Mist1 expression increases significantly after tunicamycin
treatment (Figure 5.3). Total Xbp1 mRNA amount increases ~4-fold, and its
activity as a transcription factor is most likely increasing much higher due to the
fact that tunicamycin not only increases Xbp1 transcription (through activation of
Atf6), but also its splicing to an active form (through activation of the
endoribonuclease Ire1). Downstream of Xbp1, Mist1 expression increases more
than 100-fold. Knock down of Xbp1 by siRNA, confirms that it regulates Mist1
expression in ParC5 cells (Figure 5.4). The dramatic > 100-fold increase of Mist1
during tunicamycin treatment is completely dependent on Xbp1 increase.
Cells were pretreated with siRNA targeting either Xbp1 or a non-targeting control
before treatment with tunicamycin or DMSO. Xbp1 expression was reduced 80%
by the siRNA regardless of treatment with either tunicamycin or DMSO. Mist1
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Figure 5.3: Tunicamycin Dramatically Increases Xbp1 and Mist1 but not PSP,
Rab26, or Connexin32. ParC5 cells were treatment with 1µg/ml tunicamycin for 8
hours, and gene expression was measured 16 hours later. Expression was normalized
to Rplp2. A.) Both Xbp1 and Mist1 expression increased after treatment compared to a
DMSO control (n=3, p-values= 0.03, and 0.025). Mist1 expression increased more than
100-fold. B.) Neither PSP nor Rab26 showed any change in expression after

tunicamycin treatment. (n=3, p-values= 0.18, and 0.3) C.) Connexin32 was not
detected by qPCR under any treatment. Along with tunicamycin cells were also
treated with 5-Aza-2′-deoxycytidine, a DNA methyltransferase inhibitor which has
been shown to restore expression of some genes silenced by promoter
methylation.
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expression was reduced 80% by the siRNA, but only in cells that also received
tunicamycin treatment. In the DMSO treatment group, Mist1 expression did not
change when pretreated with siRNA targeting Xbp1 (Figure 5.4). This indicates
that the increase in Mist1 expression after tunicamycin treatment is due to
promoter activation by Xbp1, and there is also a low basal level of Mist1
expression that is independent of Xbp1.
Several genes down-stream of Xbp1 and Mist1 were also measured after
tunicamycin treatment. The cargo protein and terminal differentiation marker PSP
did not change expression, and the gap junction protein connexin32 was
undetectable by qPCR in either condition (Figure 5.3). This indicates there are
other factors needed for promoter activation. In the case of Connexin32. We also
investigated the possible role of epigenetics.
Epigenetic markers have long been known to control lineage specific gene
expression. Histone modifications, largely at the promoter, can control DNA
availability leading to either silencing or activation, and DNA methylation can
silence nearby genes. The promoter of connexin32 has been shown to contain a
CpG island, and in the liver its expression can be silenced through methylation
[161]. Treatment of ParC5 cells with DNA methyltransferase inhibitors (DNMTi)
was investigated as a means to reverse silencing of terminal differentiation
genes.
5-Aza-2′-deoxycytidine (5-Aza) is a cytosine analog that is incorporated into
DNA, and will inhibit the methyl transferase enzyme by covalently trapping it to
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Figure 5.4 Mist1 is Regulated Downstream of Xbp1 in Cells Treated with
Tunicamycin not DMSO. Cells were pre-treated with a siRNA targeting Xbp1 or
a non-targeting control before tunicamycin or DMSO. A.) Xbp1 expression was
measured by qPCR. Expression is significantly reduced after pre-treatment with
the Xbp1 siRNA compared to a control siRNA regardless of whether the cells
were subsequently treated with DMSO or tunicamycin (p-values= 0.00004, and
0.003). B.) Mist1 expression was measured by qPCR. Expression is significantly
reduced after pre-treatment with Xbp1 siRNA compared to control siRNA only
when cells were subsequently treated with tunicamycin (right panel). Expression
remained unchanged in cells treated with DMSO following siRNA (left panel). (pvalues= 0.086, and 0.0025)
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the DNA. While this has been shown in many cell types to produce a
hypomethylated genome, it has the potential to be toxic due to the formation of
DNA lesions during replication.
ParC5 cells were treated with 0.25 µM of 5-Aza over 24 hours, and then were
treated with tunicamycin. Expression of Connexin32 was measured by qPCR. As
seen in Figure 5.3, Connexin32 remained undetected in all conditions.
Because of the sensitivity of these cells to 5-Aza, relatively low concentrations
and a short duration of treatment was used. DNA methylation is generally not
occurring continuously, but only during DNA replication and so several replication
cycles of treatment is needed to induce a hypomethylated genome. The nonresponsiveness of the genes measured could be due to the inability of this short
treatment to induce hypomethylation.
Surprisingly, treatment with tunicamycin resulted in decreased Rab3d expression
(Figure 5.5), and no change in Rab26 (Figure 5.3). Rabs are proteins on the
cytosolic side of the secretory vesicle which direct the secretory pathway. Our
network predicts that Mist1 activates expression of Rab3d and Rab26 in acinar
cells, and that these gene products are necessary for the differentiated
phenotype. The ability of tunicamycin to drastically increase Mist1 expression
suggests that it should also increase expression of downstream effectors, but this
does not seem to be the case in ParC5 cells.
The possibility of Mist1 acting as a repressor in these cells was next investigated.
Though Mist1 commonly activates gene expression, it has also been shown to
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Figure 5.5: Rab3d and Tcf3 Expression is Down-regulated by Tunicamycin.
A.) ParC5 cells were treatment with 1µg/ml tunicamycin for 8 hours, and gene
expression was measured 16 hours later. Expression was normalized to Rplp2.
Rab3d and Tcf3 expression is significantly down-regulated after treatment with
tunicamycin (n=3. P-value = 0.006, and 0.03). B.) Tcf3 expression during
differentiation by microarray.
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repress expression in some contexts, but the exact mechanism is unknown[152].
ParC5 cells were transfected with an expression vector containing the Mist1
coding region, and qPCR was used to measure the expression of Rab3d and
Rab26. Both Rab3d and Rab26 expression was increased after transfection of
Mist1 (Figure 5.6) indicating that it is acting as a transcriptional activator and not
a repressor.
We next examined the possibility that Mist1 must form a heterodimer in order to
activate transcription. Mist1 is a member of the basic helix-loop-helix family of
transcription factors which commonly bind DNA as heterodimers. Mist1 has been
shown to form a dimer with Tcf3 which can bind E-box regions of DNA, and our
work suggests that a Mist1/Tcf3 dimer activates PSP expression (Figure 4.5).
However, the functions of this dimer remain largely untested in the literature.
Tcf3 expression was measured by qPCR, and was shown to decrease after
treatment with tunicamycin (Figure 5.5). If a Mist1/Tcf3 heterodimer is required to
activate Rab3d expression then decrease in Tcf3 expression could result in
decreased dimer formation regardless of the expression increase in Mist1, and
this could be causing the reduction in Rab3d expression.
Our in vivo microarray measurements show that Tcf3 is moderately expressed at
every time point measured during differentiation (Figure 5.5) indicating that a
Mist1/Tcf3 dimer could be biologically relevant for in vivo development.
Tcf3 either alone or with Mist1 was transfected into ParC5 cells and Rab3d
expression was measured by qPCR (Figure 5.7). Transfection of Tcf3 alone did
121

Relative Expression

Relative Expression

2.5

Rab3d Expression
*

2
1.5

1
0.5
0

Mist1
cDNA

sport6
cDNA

1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0

Rab26 Expression
*

Mist1
cDNA

Sport6
cDNA

Figure 5.6: Mist1 is not acting as a Repressor in ParC5 Cells.
An expression vector containing Mist1 was transfected into ParC5 cells. Gene
expression was measured by qPCR 24 hours later. Expression was normalized
to Rplp2. Both Rab3d and Rab26 expression increased in cells transfected with
Mist1 compared to an empty vector. (Fold-change= 2, and 1.4 respectively, n=3,
p-values= 0.016, and 0.008).
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Figure 5.7: Tcf3 does not contribute to Mist1 Activation of the Rab3d
Promoter. A.) ParC5 cells were transfected with an expression vector containing
the transcription factor Tcf3 and expression was measured by qPCR 24 hours
later. Rab3d expression was not changed significantly by Tcf3 transfection alone
(n=3, p-value= 0.4). B.) Mist1 and Tcf3 were co-transfected into ParC5 cells, and
expression of Rab3d was measured by qPCR 24 hours later. Rab3d expression
increased significantly. (Fold-change =1.4, n=3, p-value = 0.05), but its
expression did not increase anymore that with Mist1 alone (Figure 5.6).
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not alter Rab3d expression which could be due to the low basal levels of Mist1 in
untreated cells. When co-transfected, Rab3d expression did not increase more
than Mist1 alone, indicating that heterodimer formation is likely not necessary for
promoter activation of Rab3d. Mist1 could be acting as a homodimer as it has
been reported to do in the pancreas [162].
Rab3d expression decrease could be due to other factors that are impacted by
tunicamycin treatment. Tunicamycin disrupts protein folding by inhibiting n-linked
glycosylation, and this triggers the ER stress response which activates Xbp1.
However, inhibition of glycosylation by tunicamycin is also known to alter the
activity of glycosylated transcription factors (e.g. SP1) [163, 164]. This is not
likely having an impact of Mist1 activity, which has no known or predicted
glycosylation sites, but there could be other transcription factors acting on the
Rab3d promoter which are impacted by altered glycosylation states.
5.3 Discussion
In this section, several successive edges of the network were validated in a cell
culture system. Treatment of ParC5 cells with the UPR activator tunicamycin
activated the transcription of both Xbp1 and Mist1, transcription factors that we
identified in the previous sections as important for acinar cell differentiation.
Overall, this sections validates both Xbp1 and Mist1 activation downstream of
Atf6 in our predicted network, and shows that Mist1 activation after stimulation is
due nearly entirely to Xbp1. This supports our hypothesis that Xbp1 is the main
driver of Mist1 expression during differentiation. We showed that Xbp1 is capable
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of strong Mist1 induction, which is what we observe from our in vivo
measurements.
There also seems to be a low baseline Mist1 expression that is Xbp1
independent suggesting the presence of other minor regulators. These regulators
may or may not be involved in Mist1 expression in vivo but they could be used to
explain the different acinar phenotypes that are seen in Mist1

-/- mice,, where

the

parotid acinar cells lack polarity and are completely disorganized [151], and Xbp1
-/- mice

where acinar cells in the salivary glands are smaller than wild type but are

not structurally any different [165]. Measuring Mist1 expression in Xbp1 -/- cells
could help to establish alternative regulation.
Genes further downstream in the network (i.e. PSP, Connexin32) were not
activated by tunicamycin treatment. This is probably due to unknown factors that
are involved in full expression of the network. While our microarray and qPCR
data allowed us to measure gene expression changes on a large scale, it does
not capture all the information about gene expression activation. Our dataset
does not contain information about epigenetic changes during differentiation, any
signaling pathways coming from outside the cell, or any post-transcriptional
modifications that could change transcription factor activation. A combination of
these factors is most likely involved in the gene regulatory network (Figure 3.6)
during differentiation.
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CHAPTER 6: SUMMARY
This is the first study to measure comprehensive changes in gene expression
during parotid acinar cell differentiation. The control of this cell type's
differentiation is poorly understood, and this study increases our knowledge
greatly. The networks identified could potentially be used as drivers of
differentiation in progenitor cells, which would be a step forward in being able to
regenerate salivary gland for patients suffering chronic xerostomia.
In the first results chapter (chapter 3), both mRNA and microRNA expression
were measured at several time-points spanning differentiation. This allowed the
identification of complex expression patterns, including the novel involvement of
Pparg, as well as the identification of mRNA:microRNA interactions which had
not been studied in the salivary gland differentiation before.
One of the main goals of Systems Biology is to use big datasets to generate
novel hypothesis. By integrating mRNA and microRNA data, we were able to
identify two separate microRNAs families targeting the pro-mitogenic, IGF2 at
different levels of expression, leading to the hypothesis that microRNA
expression controls cell cycle exit which could be necessary for driving
differentiation. miR-375 represses the transcription factor Plag1, which is an
activator of the IGF2 promoter, and several members of the let-7 family repress

126

IGF2BP2 an mRNA binding protein that promotes IGF2 translation. This
hypothesis could be tested in vivo using microRNA knockout mice, or a
constitutively active IGF2 transgene, and potentially these microRNAs could be
used to study differentiation in vitro.
This study is the first to identify stages specifically in the acinar cell lineage,
indicating that large gene expression changes occur rapidly in these cells at
specific time points as they differentiate. Importantly, strong changes of gene
expression were observed even several weeks after birth, the late stage of
differentiation, emphasizing the prolonged nature of parotid differentiation.
Clustering differentially expressed genes, combined with GO and transcription
factor enrichment identified for the first time the prevailing pathways and
regulatory genes during differentiation. Surprisingly, a novel role was predicted
for the transcription factor PPARg. Its expression, along with 19 of is downstream
effectors were transiently up-regulated mid-way through differentiation. The
transcription factor targets of both Xbp1 and Mist1 are enriched in a cluster of
genes that increase during differentiation.
64 microRNAs are differentially expressed during differentiation (52 are upregulated and 12 are down-regulated). These include miR-375 which increases
more than 800-fold, and likely inhibits Plag1 expression, making it an important
regulator of proliferation in the postnatal period and possibly of differentiation by
inhibiting mitogenic factors.
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In chapter 4, mRNA and microRNA expression measurements were integrated
into a model gene regulatory network driving the expression of terminal
differentiation markers PSP, Rab3d, Rab26, and Connexin32. This network
incorporates three main arms.
In the pro-stemness arm, pro-stem cell transcription factors such as Klf4 and
Sox11 are expressed relatively highly in the embryo, and decrease during
differentiation due to targeting by several microRNAs. As shown in chapter 3 with
the let-7 family, several microRNAs are acting together to regulate a target gene.
In the genetic switch, expression of Pax5 decreases across differentiation due to
decreased expression of Sox11 and transient up-regulation of Prdm1 which
represses expression. Finally, in the pro-differentiation arm, Xbp1 expression
increases due to decreased repression by Pax5 and miR-214. At the same time,
Xbp1 expression is activated by increasing Atf6. Terminal differentiation markers
are activated downstream of Xbp1 and Mist1.
These transcription regulatory networks are likely necessary for promoting
differentiation in a progenitor cell or a stem cell, and would need to be activated
in cells used for salivary regeneration. This network provides several prospective
targets which could be activated (Xbp1, Mist1) or repressed (Klf4, Sox11) in
order to drive differentiation in culture and regrow acinar cells for transplantation.
Individual interactions from the network were validated in vitro by luciferase
assay, and in chapter 5, multiple steps of the network were tested at once in a
cell culture model. Using tunicamycin, transcription of Xbp1 and Mist1 was
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activated, but genes further downstream (PSP, Rab3d, Connexin32) were not.
This could be due to epigenetic changes in the cell line used, or the absence of
extracellular signaling that could be involved in differentiation in vivo such as
signaling between the epithelium and that mesenchyme or the parasympathetic
ganglion.
Future work is needed to expand this network to incorporate factors not included
in the current design such as extracellular signaling pathways and epigenetic
changes which are important for differentiation. Nonetheless, the genes identified
in this network and in the analysis of expression changes during differentiation,
provide additional targets and markers for research into bioengineering or
regeneration of salivary glands.
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